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One sentence summary: Connection target specificity in inhibitory neurons is 
conferred by cell-specific expression of synaptic molecules. 
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ABSTRACT 
How neuronal connections are established and organized in functional networks 
determines brain function. In the mammalian cerebral cortex, different classes of 
GABAergic interneurons exhibit specific connectivity patterns that underlie 
their ability to shape temporal dynamics and information processing. Much 
progress has been made parsing interneuron diversity, yet the molecular 
mechanisms by which interneuron-specific connectivity motifs emerge remain 
unclear. Here we investigate transcriptional dynamics in different classes of 
interneurons during the formation of cortical inhibitory circuits in mouse. We 
found that whether interneurons synapse on the dendrites, soma or axon initial 
segment of pyramidal cells is determined by synaptic molecules that are 
expressed in a subtype-specific manner. Thus cell-specific molecular programs 
that unfold during early postnatal development underlie the connectivity 
patterns of cortical interneurons.  
 
MAIN TEXT 
 
Different classes of neurons connect with exquisite specificity to form neuronal 
circuitries. Brain wiring is most complex in the cerebral cortex, that includes 
excitatory pyramidal cells and inhibitory GABAergic interneurons, of which over two 
dozen types have been identified (1). Different types of interneuron target distinct 
subcellular compartments in pyramidal cells. For example, somatostatin-expressing 
(SST+) interneurons primarily contact the dendrites of pyramidal cells, whereas 
parvalbumin-expressing (PV+) basket cells make synapses on neuronal somata and 
proximal dendrites. Chandelier cells, instead, innervate the axonal initial segment 
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(AIS) of pyramidal neurons (2). Compartment-specific inhibitory control confers 
advanced computational capabilities to neurons (3, 4). Here we study in mouse the 
mechanisms regulating compartment-specific wiring of interneuron outputs in cortical 
microcircuits. Molecular signatures identify types of interneuron in the adult mouse 
cerebral cortex (1, 5, 6). However, cell type-specific transcriptional differences may 
drive subcellular patterns of inhibitory connectivity and may be restricted to early 
postnatal development, when synapses are formed.  
To identify cell type-specific molecular programs controlling the subcellular 
connectivity of SST+, PV+ basket and chandelier interneurons, we first analyzed the 
temporal dynamics of inhibitory synapse formation for each of these populations (fig. 
S1). Postnatal day (P) 10 marks the initial surge of synaptogenesis for all three classes 
of interneuron (fig. S1). These results provided us with a developmental time window 
for searching gene expression differences underlying the establishment of type-
specific interneuron connectivity. 
To identify genes that are differentially expressed between different classes of 
interneurons during inhibitory synapse formation, we used fluorescence-activated cell 
sorting to isolate interneurons from genetically modified mice in which dendritic-, 
somatic- and AIS-targeting GABAergic interneurons are enriched and labeled (table 
S1) (7–12). We isolated interneurons both prior (P5/P8) and during peak (P10) 
synaptogenesis. To ensure cell type and developmental stage specificity, we also 
isolated several control populations: interneurons at P0, pyramidal neurons at the peak 
of glutamatergic synaptogenesis (P12, (13)) and oligodendrocytes at P10 (table S1 
and S2). We then performed RNA-sequencing (RNAseq) and whole-transcriptome 
analyses on each of these cell populations to identify the molecular programs that 
distinguish different interneuron types between P5 and P10 (Fig. 1A and fig. S2A; 
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https://devneuro.org/cdn/gene_tool_1.php). Gene expression profiles from different 
types of interneuron showed similar patterns of distribution, consistency across 
biological replicates, accurate segregation for each cell type and suitability of the 
selected developmental time points (fig. S2). 
To query which molecules regulate interneuron synapse specificity, we first 
identified differentially expressed (DE) genes among distinct types of interneuron 
during the initial period of synaptogenesis (Fig. 1). Differential expression analysis 
revealed type-specific gene expression at P10 (Fig. 1B and fig. S3C). Gene Ontology 
(GO) analysis revealed that the most enriched genes belong to synaptic, nearby 
membrane compartments and included processes that contribute to synaptogenesis 
(Fig. 1C and D, and fig. S3). Notably, comparison of our dataset with recent scRNA-
seq studies from the adult mouse cortex unveiled that many genes that are type-
specific during development are not detected as such at later stages (fig. S4-S6). 
Altogether, these analyses indicate that distinct transcriptomic profiles emerge in 
developing interneurons and that a large proportion of the type-specific signatures are 
restricted to the time of synapse assembly (P5-P10). 
To single out genes with the highest degree of type and stage specificity, we 
ranked DE genes using a specificity ratio ((14), see Methods). Our analyses (i) 
indicate that different interneurons acquire distinct molecular signatures while they 
first establish synaptic contacts (Fig. 1E) and (ii) revealed several gene subsets 
potentially involved in the establishment of distinct inhibitory motifs (dendrite-, 
soma- and AIS-targeting) in the developing cerebral cortex (Fig. 2A, S7 and table S3 
and S4). Indeed, our data showed that distinct members of synaptic protein families 
are often differentially utilized by interneuron subclasses during development (Fig. 
2B and Fig. S8). Focusing on genes that had a putative or established synaptic 
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function (Fig. 2A and B), we identified and validated those that exhibited the highest 
specificity (Fig. 2, S9 and S10). Such validation yielded three candidate genes that we 
further studied to demonstrate that inhibitory synapse specificity is conferred by cell-
specific expression of synaptic molecules. The leading candidate for regulating 
dendrite-targeting inhibitory synapses was Cbln4, a member of the C1q family that is 
a bidirectional synaptic organizer (15, 16). Leucine rich repeat LGI family member 2 
(Lgi2), that belongs to a protein family involved in synapse maturation (17), emerged 
as a promising candidate to regulate the development of perisomatic inhibitory 
synapses. Finally, Fgf13, which encodes an intracellular protein with multiple 
functions including a microtubule stabilizing role (18–21), was our candidate for AIS-
targeting chandelier synapses. Supporting our hypothesis that these genes aid 
inhibitory synapse development, Lgi2 and Fgf13 dysfunction has been linked to 
disorders characterized by disrupted excitatory/inhibitory balance (22–24). 
We examined mRNA or protein expression for our candidate genes and 
confirmed that their expression increased during the second postnatal week (Fig 2C). 
We also confirmed that in the cerebral cortex, both at P10 and P30, Cbln4, Lgi2 and 
Fgf13 are enriched in SST+, PV+ and chandelier cells, respectively (Fig. 2D and E, 
fig. S10 and fig. S11). Examining the proportion of interneurons of each type that 
express our candidate genes, one can see that Cbln4 and Fgf13 are ubiquitously 
expressed by all SST+ interneurons and chandelier cells, respectively, whereas Lgi2 is 
confined to a subpopulation of PV+ basket cells (Fig. 2D and E and fig. S10).  
To investigate the role of Cbln4, Lgi2 and Fgf13 in the development of different 
types of GABAergic synapses, we used a hybrid conditional gene knock-down 
strategy based on cell-type specific Cre-driver lines combined with adeno-associated 
viral vectors (AAV) and performed cell type-specific loss-of-function experiments in 
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vivo (25). In brief, we engineered Cre-dependent conditional constructs expressing 
miR-based short-hairpin RNAs against candidate genes (shCbln4, shLgi2, shFgf13) 
and controls (shLacZ and shGfp) in which recombination was reported by mCherry 
(fig. S12A). We confirmed the effectiveness of our constructs in downregulating 
Cbln4, Lgi2, Fgf13 expression (fig. S12, B to E). 
Compared to controls, cell-specific downregulation of Cbln4 in SST+ cells, Lgi2 
in PV+ basket cells and Fgf13 in chandelier cells led to a decrease in the density of 
presynaptic inputs (mCherry+) that these interneurons make onto the corresponding 
subcellular postsynaptic compartments of pyramidal cells (Fig. 3 and fig. S13). We 
observed that Fgf13-deficient chandelier cells also showed axonal disorganization 
(fig. S14, A to D), which was instead not found in SST+ or PV+ basket cells upon 
downregulation of Cbln4 and Lgi2, respectively (fig. S15). The axonal phenotype of 
Fgf13-deficient chandelier cells may contribute to their decreased innervation of the 
AIS. Nevertheless, the reduced density of chandelier synaptic boutons persisted when 
Fgf13 was downregulated after P14 when the axonal phenotype was, instead, not 
observed (fig. S14, E to H), suggesting two different functions of the protein.  
Control as well as rescue experiments showed that our phenotypes are explained 
by specific downregulation of the target genes rather than off-target effects and did 
not include an altered interneuron density (figs. S16, S17 and S18). Moreover, GluD1 
and ADAM22 – CBLN4 and LGI2 putative trans-synaptic partners (23, 26) – are 
located at the SST+ and PV+ synapses, respectively (fig. S19). 
Altogether, these experiments revealed that Cbln4, Lgi2 and Fgf13 are required 
for the development of dendrite-, soma- and AIS-targeting synapses made by SST+ 
interneurons, PV+ basket cells and chandelier cells, respectively. Such one to one 
matching of molecules to cell types uncovers that the connectivity patterns of cortical 
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interneurons rely on synaptic protein repertoires that are selective for each type of 
interneuron. Notably, Cre-dependent knockdown of Pcdh18 – another 
developmentally regulated molecule specifically expressed in SST+ cells (Fig. 2A and 
S20, A to F) – led to an increase in the density of SST+ dendritic synapses (Fig. S20, 
G to J). Thus, our screening is a valuable resource for identifying molecules 
regulating diverse aspects of inhibitory synapse assembly and specificity. 
The subcellular localization of presynapses defines the efferent specificity in each 
type of interneuron. We, therefore, asked whether the identified cell-specific synaptic 
molecules can regulate synapse formation independently of the subcellular location of 
presynaptic terminals. To this end, we focused on Cbln4 because C1q family proteins 
can induce synapse formation (16). We first validated the synaptic deficits observed 
following loss of Cbln4 in SST+ interneurons. Specifically, we injected AAV viruses 
expressing Channelrhodopsin-2 (Chronos) following Cre-mediated recombination 
along with control or shCbln4 vectors (Fig. 4A). Cbln4 downregulation in SST+ 
interneurons did not affect their spiking output or membrane properties in response to 
photostimulation (Fig. S21). We recorded from pyramidal neurons and stimulated 
ChR2+ SST cells with wide-field illumination of increasing intensity, finding that the 
peak amplitude of optogenetically-evoked inhibitory postsynaptic currents (IPSCs) 
was reduced in knockdown animals versus controls (Fig. 4B to D). Minimal intensity 
stimulation experiments revealed a decrease in IPSC amplitude in cells recorded from 
knockdown animals (Fig. 4D). These findings suggest a decrease in synaptic weights 
for SST outputs to pyramidal cells, offering a functional correlate consistent with the 
structural synaptic deficits caused by downregulation of Cbln4 in SST+ cells (Fig. 3B 
and C).  
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Next, we investigated whether Cbln4 is sufficient to trigger the formation of 
domain-restricted synapses. We observed that overexpression of a HA-tagged CBLN4 
in SST+ interneurons leads to an increase in dendritic inhibitory synapses (Fig. 4E to 
F). In contrast, ectopic expression of CBLN4 in PV+ basket cells or chandelier cells 
did not promote synapse formation on the soma or AIS of pyramidal cells but caused 
a specific increase in PV+ dendritic synapses (Fig. 4G to L and fig. S22). These 
results indicate that Cbln4 expression does not trigger generic formation of all 
inhibitory synapses. Rather, Cbln4 promotes the formation of GABAergic synapses 
onto the dendrites of pyramidal cells, a feature that is distinctive of SST+ 
interneurons. 
Our study reveals transcriptional dynamics for different classes of interneurons 
from P5 to P10 in postnatal development of the mouse, when inhibitory circuits are 
established in the cerebral cortex. Although post-transcriptional processes (e.g. local 
translation) are likely to play an additional role, our results describe a relationship 
between cortical interneuron development and diversity. We demonstrate that 
different classes of interneurons rely on largely non-overlapping molecular programs 
for the establishment of distinct types of inhibitory synapses. In particular, we show 
that three molecules — CBLN4, LGI2 and FGF13— regulate the development of 
SST+, PV+ basket and chandelier synapses, respectively. Specifically, CBLN4 is able 
to promote the assembly of dendritic but not somatic or axo-axonic inhibitory 
synapses. These results demonstrate how the cell-specific expression of synaptic 
molecules together with their ability to promote compartment-specific synapse 
formation critically contributes to the specific wiring of the inhibitory circuits. 
Insight into the organizing principles of cortical inhibitory circuits will help 
deciphering neurodevelopmental disorders linked to inhibitory circuit dysfunction 
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(24, 27). Much progress has been made towards understanding interneuron diversity 
during embryonic development or in the adult cortex (1, 6, 28–30). Our work reveals 
that selective type-specific genetic programs emerge during postnatal development in 
cortical interneurons to support the exquisite precision of inhibitory connections, 
thereby assembling inhibitory circuits. Since some of these genes continue to be 
expressed in mature cortical interneurons (1, 5, 6), it is conceivable that they also 
contribute to the maintenance and plasticity of specific inhibitory circuitries. 
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FIGURE LEGENDS 
 
Fig. 1. Identification of cell type-specific molecular programs for interneurons postnatal 
development. (A) Schematic of experimental workflow. (B) Heatmap showing P10 interneuron-
subtype enriched genes. (C and D) GO analysis using P10 subtype-specific genes: terms associated 
with synapses (C, see fig. S3) and cellular functions (D). (E) Heatmaps showing the top 25 
differentially expressed genes exhibiting the highest degree of subtype and stage specificity. 
 
Fig. 2. Expression of subtype-specific synaptic genes. (A) Top 5 candidate subtype-specific 
‘synaptic’ genes. Asterisk: synaptic function by similarity. (B) Ternary diagrams showing subtype and 
time differences in expression (light colors P5, darker P10, grey not enriched). (C) Developmental 
expression of Cbln4 and Lgi2 in the somatosensory cortex (qPCR, Lgi2 values are x10-5) and Fgf13 
(IHC, fluorescence intensity in arbitrary units x10-2) in layer II-III of prefrontal cortex (n ≥ 3 mice for 
each stage). One-Way ANOVA (Cbln4 and FGF13) or Kruskal-Wallis test (Lgi2) and Tukey’s or 
Dunn’s multiple comparisons test. ***p<0.001, *p<0.05; significance shown only for P5-P10 
comparisons. (D) Expression of Cbln4, Lgi2 and FGF13 in SST+, PV+ basket and chandelier cells, 
respectively. Scale bars equal to 20 μm. (E) Specificity of Cbln4, Lgi2 and FGF13 expression (left 
column). Fraction of SST+, PV+ basket and chandelier cells expressing Cbln4, Lgi2 and FGF13 (right 
column). “ChCs est”, estimated number of chandelier cells (Fig S4, E to G). Data are mean ± SEM. 
 
Fig. 3. Genetic specification of interneuron synapse formation. (A) Schematic of AAV injections. 
(B to C) Representative image, Imaris reconstruction and density of GAD65+ boutons inside 
mCherry+ axons of SST+ cells infected with control (n = 8 mice) or shCbln4-expressing viruses (n = 7 
mice) contacting Gephyrin+ clusters in layer I. **p<0.01, Student t-test. (D to E) Representative 
images, Imaris reconstruction and density of mCherry+Syt2+ synapses made by PV+ basket cells 
infected with control (n = 5 mice) or shLgi2-expressing virus (n = 6 mice). **p<0.01, Student t-test. (F 
to G) Representative images, Imaris reconstruction and density of mCherry+ synapses made by 
chandelier cells induced with Tamoxifen and infected with control (n = 18 cells from 3 mice) or 
shFgf13-expressing viruses (n = 18 cells from 5 mice). ***p<0.001, Student t-test. Scale bars equal 1 
μm. Data are mean ± SEM. 
 
Fig. 4. Synaptic function and target specificity for SST population. (A) Schematic of experimental 
paradigm (n= 18 cells from 9 and 7 mice for control and shCbln4-expressing viruses, respectively). (B) 
IPSC peak amplitude as a function of irradiance, ***p<0.001, Two-Way ANOVA. (C) Representative 
IPSC traces. (D) IPSC amplitude under minimal intensity, *p<0.05, Mann-Whitney test. (E to F) 
Representative image, Imaris reconstruction and density of GAD65+ boutons inside mCherry+ axons 
of SST+ cells infected with control (n = 9 mice) or Cbln4-HA-expressing virus (n = 8 mice) contacting 
Gephyrin+ clusters in layer I. ***p<0.001, Mann-Whitney test. (G to J) Representative images, Imaris 
reconstruction and density of mCherry+Syt2+ synapses made onto pyramidal cell soma or dendrites by 
PV+ basket cells infected with control (n = 5 mice) or Cbln4-HA-expressing virus (n = 5 mice). ns, 
Student t-test (H), * p<0.05, Mann-Whitney test (J). (K to L) Representative images, Imaris 
reconstruction and density of mCherry+ synapses made by chandelier cells induced with Tamoxifen 
and infected with control (n = 12 cells from 3 mice) or Cbln4-HA-expressing virus (n = 17 cells from 5 
mice). ns, Student t-test. Scale bars equal 1 μm. Data are mean ± SEM.  
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Materials and Methods 
Mice 
PVCre/+ (31), PLPGFP/+ (32), Nkx2-1Cre/+ (33), NexCre (34), SstCre/+ (Jackson 
Laboratories #13044), Ai9 (Jackson Laboratories #7909) and RCE (Jackson Laboratories 
#32037) were maintained in a C57BL/6 background (Charles River Laboratories); GIN 
mice (Jackson Laboratories #003718) were maintained in an FVB/NJ background, G42 
mice (Jackson Laboratories #007677) were maintained in a CB6F1/J background and 
Nkx2-1CreER/+ mice (9) were maintained in a 129S2/SV background. Animals were 
maintained under standard, temperature controlled, laboratory conditions. Mice were kept 
on a 12:12 light/dark cycle and received water and food ad libitum. Animal procedures 
were approved by ethical committees (IN-CSIC and King’s College London) and 
conducted in accordance with Spanish and European regulations and Home Office 
personal and project licenses under the UK Animals (Scientific Procedures) 1986 Act. 
 
Choice of transgenic lines, regions and postnatal stages for RNA-seq 
We selected specific subpopulations of GABAergic neurons that were fluorescently 
labeled and highly and/or exclusively represented in particular areas: dendritic-targeting 
interneurons (GIN strain, somatosensory cortex- mostly Martinotti cells (8, 11)), somatic-
targeting interneurons (G42 strain, prefrontal lower layers, PV+ basket cells (7, 11)) and 
AIS-targeting interneurons (Nx2.1CreERT2;Ai9 strain, upper layers- mostly chandelier 
cells upon early postnatal tamoxifen inductions (P2), (9) Fig. 1, Table 1). It is important 
to mention that, because P2 tamoxifen inductions label the very last temporal cohort of 
chandelier cells, several of these cells are still migrating at P5 (data not shown). To avoid 
isolating migrating chandelier cells that would “contaminate” our transcriptome data with 
genes involved in chandelier cell migration rather than synapse formation, we decided to 
sort chandelier cells at P8 and P10, instead of P5 and P10 (Table 1). Note that it is not 
possible to unequivocally identify chandelier cells by morphology before P12 (i.e. at 
P10). Since no chandelier cell is labeled in the lower layers of the G42 prefrontal cortex 
(12, 35), this region has the additional advantage of restricting GFP expression 
exclusively to the PV+ basket cell population, as it also excludes other PV+ cells such as 
bi-stratified cells (12). In contrast, Nkx2-1CreER/+ subpopulation, although enriched in 
chandelier cells, still labeled a small fraction of non-chandelier cells. Since knowing the 
identity of these cells was critical to ensure a correct interpretation of the chandelier cell 
transcriptome data, we crossed Nkx2-1CreER/+ mice with the Ai9 reporter line and 
colocalized Tomato+ cells with markers (data not shown). At P30, the majority of 
Tomato+ cells in the upper layers of the PFC were chandelier cells, both PV+ and PV-. 
We also found a 16% of PV+ basket cells. The remaining 10% were mostly Reelin-
expressing neurogliaform (RELN+SST-) interneurons derived from the preoptic area 
(POA) (36) and oligodendrocytes. To exclude genes that might not be playing a specific 
role in synapse formation, we obtained additional profiles using different reporter lines 
(Table 1). For example, for genes that might be involved in earlier stages of development, 
we used Nkx2-1Cre/+;RCE at P0. For genes participating in general process of synapse 
formation, we use a pyramidal cell reporter line (NexCre/+;RCE) at P12, when we 
observed the first increase in excitatory synapse formation (37). Finally, to remove genes 
that were expressed in Nkx2-1CreER/+;Ai9 oligodendrocytes and not chandelier cells we 
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used PLPGFP/+ mice at P10. Since GIN is a transgenic mouse line, the full population of 
cells labeled by GFP cannot be assumed and has to be characterized. All studies that have 
used the GIN mice to analyze somatostatin cells have been performed in the 
somatosensory cortex. We, therefore, reasoned that it was the most accurate area to 
ensure pure sorting of somatostatin interneurons (8, 11, 38, 39). Moreover, recent work 
showed that interneurons subtypes from different cortical areas (including SST+ cells) 
are transcriptionally similar (40). 
 
Background and regional differences 
The mouse lines used for RNA-seq have a different background. To confirm that we 
could reproduce our findings in a homogenous background, all validations of the specific 
expression (in situ hybridization and immunohistochemistry) as well as the 
developmental upregulation (qPCR) of Cbln4, Lgi2 and Fgf13 (and Pcdh18) were 
consistently done in a C57BL/6 background. Moreover, downregulation, rescue and 
overexpression experiments were also consistently performed in a C57BL/6 background. 
Regarding the regional differences, as reported above, recent work showed that 
interneurons subtypes from different cortical areas are transcriptionally similar (40).  
 
Tissue dissociation and FACS 
To isolate individual cells, we euthanized the corresponding transgenic mice (Table 
1), extracted the brain and microdissected the region of interest in cold pH 7.3 
dissociation media containing 14 mM MgCl2, 2 mM HEPES (Invitrogen 15630-106), 0.2 
mM NaOH (Sigma S0899), 90 mM Na2SO4 (Sigma S6547), 30 mM K2SO4 (Sigma 
P9458), 3.6 mg/mL D-(+)-Glucose (Sigma G6152), 0.8 mM kynurenic acid (Sigma 
K3375), 50 μM AP-V (Sigma A5282), 50 U/mL penicillin/streptomycin (Thermo Fisher 
15140122). Brain regions were identified using histological landmarks (e.g. size and 
shape of the corpus callosum, big blood vessels, etc.). Regarding the specific layers, the 
experimenters were trained in the dissection for several weeks as follows: first, upper 
layers containing tdTomato+ cells or lower layers containing GFP+ cells were dissected 
under a fluorescent microscope. In the second phase of the training, the distribution of 
tdTomato+/GFP+ cells under a fluorescent microscope before dissection was used to 
identify histological landmarks. The accuracy of the dissection was then verified under a 
fluorescent microscope. Third, the experimenters would perform the layer dissection and 
then verify the outcome under a fluorescent microscope. To generate single-cell 
suspensions, 1 mm3 tissue pieces from 1-3 brains were pooled and enzymatically digested 
in dissociation medium containing 0.16 mg/mL cysteine (Sigma C9768), 7 U/mL Papain 
(Sigma P3125), 0.1 mg/mL DNase (Sigma 10104159001) at 37˚ C for 30 minutes. Papain 
digestion was then blocked with dissociation medium containing 0.1 mg/mL ovomucoid 
(Sigma, St. Louis, MO T2011) and 0.1 mg/mL bovine serum albumin (BSA, Sigma 
A4161) for 1 minute at room temperature. Neurons were mechanically dissociated to 
create a single cell suspension in iced OptiMEM solution containing 3.6 mg/mL D-(+)-
Glucose, 4 mM MgCl2, 0.4 mM kynurenic acid, 25 μM AP-V, 0.04 mg/mL DNase 
diluted in OptiMEM medium (Thermo Fisher, 31985). Cells were centrifugated at 120 g 
for 5 minutes at 4˚ C, resuspended in 150-300 μL of fresh complemented OptiMEM and 
passed through a 40 μm cell strainer. Fluorescently labeled individual cells were then 
purified from the suspension by fluorescence-activated cell sorting (FACS) using a BD 
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FACSAria III cytometer. Cells from 1-3 consecutive experiments were collected in 350 
μl of RLT buffer (RNeasy Lysis buffer, QIAGEN) containing 1% 2-Mercaptoethanol and 
stored at -80°C for RNA extraction.  
 
RNA sequencing and differential expression analysis 
RNA was extracted using the QIAGEN RNeasy Micro Kit according to 
manufacturer's instructions. Library preparation and RNA-seq experiments were 
performed by the Genomic Unit of the Centre for Genomic Regulation (CRG, Barcelona, 
Spain). Depending on the cell type and stage, approximately 7,000-30,000 cells were 
required to obtain 1-2 ng of total RNA, which served as input for the library preparation 
using the SMARTer Ultra Low RNA Kit for ultra-low amount of RNA. The Illumina 
HiSeq 2000 platform was used to sequence libraries to a mean of approximately 50 
million mapped 50 base pair single-end reads per sample. In the RNA-seq experiments, 
three biological replicates were ascertained for each dataset, except for oligodendrocytes 
where two replicates were used. 
Bioinformatic analysis of RNA-seq data was performed by the Bioinformatic Unit at 
the CRG. RNA-seq quality check was performed using the tool FastQC (41). The goal of 
this step was to provide an overview of the quality of the data such as: per base sequence 
quality, GC content, duplication level, amount of overrepresented regions and presence of 
adapters. To confirm a low amount of rRNA contaminations, we extracted a subset of 1 
million reads for every sample and aligned them against a database of rRNAs using the 
tool ribopicker (42). Consistent with the presence of a step for filtering by polyA 
selection in the RNA-seq protocol, we obtained a low amount of reads mapping to 
rRNAs (0.6-4.1%). Next, reads were aligned to the reference mouse genome (Ensembl 
release 66 corresponding to the Build 37 assembly, NCBIM37/mm9) using Tophat2 (43), 
a splice aware mapper for RNA-seq reads that uses known information of splicing events 
to align reads spamming the junction of two exons. We successfully mapped 75.2 ± 
13.5% of the fragments to the genome. 
Gene expression levels were reported in fragments per kilobase of transcript per 
million fragments mapped (FPKM) as a measure of the normalized abundances of 
transcripts. The Cufflinks method was used to compute FPKM values (44). FPKMs and 
read counts were scaled via the median of the geometric means of fragment counts across 
all libraries. Each replicated condition was used to build dispersion models, that were 
then averaged to provide a single global model for all conditions in the experiment. 
Differential expression analysis was performed using Cuffdiff2 to compare all pairs of 
conditions (45). The adjusted p-values for multiple comparisons (q-values or false 
discovery rate, FDR) were calculated using the Benjamini-Hochberg procedure as a 
method for multiple-testing correction. The cummeRbund R package from Bioconductor 
(46) was used for gene specificity analysis, data visualization, principal component (PC) 
analysis and Jensen-Shannon (JS) distance between replicates and samples. RNA-seq 
data have been submitted and have been assigned the following GEO accession number: 
GSE120161. R scripts for gene expression analyses are available on GitHub: 
https://github.com/rico-lab/synapdomain-favuzzi. 
 
Analysis of gene expression specificity 
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To detect the genes that exhibit the highest degree of both subtype and stage 
specificity, we calculated specificity ratios for each cell population. We first selected all 
genes differentially expressed among P10 SST+ cells, P10 PV+ basket cells, and P10 
chandelier cells, using a threshold of FDR < 0.05 for all pair comparisons with the other 
cell populations. To remove genes with high specificity owing to barely detectable 
expression, we additionally filtered them by a minimum normalized expression level 
(FPKM) of 10. Next, we further filtered our gene lists for each interneuron subtype by 
subsetting those genes that were developmentally upregulated between P5/8 and P10 
stages. Finally, we ranked all significantly differentially expressed genes using a 
specificity ratio based on the fold change between the gene’s normalized expression in a 
given interneuron subpopulation at P10 and the maximum expression level of that gene in 
the other cell types. The specificity ratio was calculated as the log2 transform of the fold 
change (log2FC) between the expression of a gene within a given interneuron population 
and the maximal expression across all other cell populations (14). For heatmaps in Figure 
1E, we applied the specificity ratio to the three interneuron subtypes at both 
developmental stages (P5/8 and P10), interneurons at P0, pyramidal cells and 
oligodendrocytes. In these heatmaps, genes were ranked based on the gene specificity of 
the corresponding interneuron subpopulation at P10. For data visualization in the 
heatmaps in Figure 1B, we filtered genes by a minimum FPKM of 5, applied the 
specificity ratio to all populations at P10/12 and selected the top 100 genes. 
A list of genes expressed in P12 pyramidal neurons but not in interneurons (37) was 
used as additional filter applied to the list of SST cell-specific genes. This was due to the 
labeling of a population of pyramidal cells in the lower layers of the more lateral 
somatosensory cortex of GIN mice (data not shown). 
Of all genes exhibiting both subtype and stage specificity, we selected those that had 
a demonstrated or putative role in axon growth, axonal pathfinding, neuron-ECM 
communication or cell-cell adhesion, according to the gene ontology analysis or a manual 
MEDLINE® search. 
 
Gene Ontology analysis 
Gene Ontology (GO) analysis was performed to identify which gene classes 
distinguish SST+, PV+ basket and chandelier cells at P10. We used the “GOstats” and 
“ggplot2” R packages for data analysis and visualization, respectively. Differentially 
expressed genes between cell populations sorted at P10/P12 (interneuron subtypes, 
pyramidal cells, and oligodendrocytes) (FDR < 0.05) were used for the GO analysis. We 
applied a threshold of FPKM > 5 to remove genes with low expression levels. Specificity 
ratios were calculated for the three interneuron subpopulations at P10 as described above 
and genes exhibiting a log2 specificity ratio > 1.5 were selected. For the GO analysis 
relative to the Cellular Component category (Figure 1C and S3) the top 100 enriched 
genes for each interneuron subpopulation were used as input lists for the GO analysis. 
Enrichment scores for significant GO terms of the Cellular Component category were 
given as the log10 transformation of the p-value. For the GO analysis about the cellular 
functions (Figure 1D), the 50 most highly enriched genes were used as input. 
 
Gene expression comparison with adult scRNAseq datasets 
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The “ggplot2” R package was used for violin plots depicting the gene expression of 
developmentally-regulated genes in single cell RNAseq studies from the adult cortex (1, 
5, 6). To quantify the relative proportion of developmental genes that distinguish cell 
identities in the adult, we calculated the expression enrichment between the different 
clusters in each study. For Zeisel et al. 2015 (5), we divided the averaged expression of 
each candidate gene in single cells pooled from the SST+ clusters (named as “Int1”, 
“Int2”, and “Int4” in the original paper) and single cells pooled from the PV+ cluster 
(named as “Int3”). For Tasic et al. 2016 (1), we divided the averaged expression of each 
candidate gene in single cells pooled from the 6 SST+ cell types (yellow colours in the 
original paper) and single cells pooled from the 7 PV+ cell types (red colours in the 
original paper). For Paul et al. 2017 (6), we divided the averaged expression of each 
candidate gene in single cells pooled from a particular cell type (Martinotti cells, PV+ 
basket cells, or chandelier cells) and the mean expression between the other two cell 
types. Differential expression was set with a cut-off value of 2 for all three adult 
databases. 
 
Interneuron-pyramidal cell molecular pairs 
Cell-specific candidate molecules were selected based on their specificity ratio 
(calculated as described above) as well as synaptic role based on the gene ontology 
analysis or a manual MEDLINE® search. To obtain a longer input list, we eliminated 
some of the restrictions that were instead applied to obtain the top 5 molecules in Fig. 2A. 
In particular, we included molecules that were also expressed in P0 interneurons as well 
as molecules that did not show strong upregulation between P5/P8 and P10. To identify 
putative trans-synaptic partners, the list of cell-specific candidate synaptic genes was 
used as input in BioGRID (47) and STRING (48), two different databases of protein-
protein interactions, as well as in a MEDLINE® search (see Table S4 for details). Among 
the interactors, only membrane proteins were selected (e.g. intracellular interactions were 
excluded). From the STRING database, only experimentally validated partners were 
selected. Interactors that appeared in STRING based on text mining were occasionally 
selected, i.e. only when the gene resulted expressed and highly enriched in pyramidal 
neurons. For each interactor, the expression level and specificity ratio in pyramidal 
neurons were computed. Only interactors that had FPKM > 5 in pyramidal neurons were 
reported. The specificity ratio was then used to rank the putative trans-synaptic partners 
and, consequently, the associated synaptic molecules. 
 
Ternary diagrams 
For each gene, a cell type specificity score was calculated based on the expression 
across the different interneuron subpopulations at both developmental stages (P5/8 and 
P10). Such specificity score is based on the JS divergence and quantifies the similarity 
between the expression profile of a given gene and the expression pattern of the extreme 
case in which a gene is present only in one population. We used this entropy-based metric 
as described before (49). The “cummeRbund” R package was used for calculating the 
specificity score that was then normalized to 1. The expression and specificity of protein 
family members were visualized in ternary diagrams by using the “ggtern” R package. In 
the relevant figures, the dot size corresponds to the maximum level of expression of each 
gene (log2FPKM+1) in the three subpopulations at P5/8 or P10. Differentially expressed 
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genes are represented with solid outlines (FDR < 0.05). Enriched genes are color-coded 
for a particular interneuron population based on the cell-type specificity score (>0.45). 
Gray colors identify genes that did not show enrichment for any interneuron subtype. 
Genes highlighted in bold show a 2-fold or higher upregulation in their expression levels 
(FPKM) between both developmental stages. 
 
Quantitative real-time PCR 
Total RNA was extracted from mouse brain tissue using TRIzol reagent (Invitrogen) 
followed by DNase I treatment (Promega). For Cbln4 and Lgi2 mRNA expression level 
analysis in Figure 2, 18S was used as reference gene. For Cbln4 and Lgi2 mRNA 
expression level analysis on the infected mouse brain tissue in Fig. S12D, mCherry and 
18S were used as reference genes, respectively. We did not consider mCherry as the 
appropriate reference gene to assess Lgi2 expression because, in contrast to Cbln4, not all 
infected mCherry+PV+ cells would also be Lgi2+. For Lgi2 mRNA expression level 
analysis on the infected mouse brain tissue in Fig. S12D, to avoid contamination with 
Lgi2+ subplate neurons (that also express Lgi2) layer VI was excluded from the 
dissection when Lgi2 expression was assessed. cDNA synthesis was performed using the 
SuperScript IV First-Strand Synthesis System (Invitrogen) according to manufacturer’s 
protocol. qPCR was carried out in triplicates on a LightCycler 480 Instrument (Roche) 
using SYBR Green PCR Master Mix (Roche). The sequences of qPCR primers were as 
follows: Cbln4 (Fw: AGT CTA CCA GAG CCA AAC CAT CC, Rv: TTA GTG GCG 
GCT TCA CGG GTC AC), Lgi2 (Fw: CAC CGT CTC TGA TGT GCT GTGT, Rv: ACT 
GGT ACG GCA GAG TCT GATG ), 18S (Fw: GTA ACC CGT TGA ACC CCA TTC 
GT, Rv: GTG TGT ACA AAG GGC AGG GAC TTAA), mCherry (Fw: CAT CCT GTC 
CCC TCA GTT CATG, Rv: CAT CCT GTC CCC TCA GTT CATG), Pcdh18 (Fw: 
CGG ACG GGA GAA TTC CAG CAG, Rv: TAG TCA GAG GAT GGC GAG GGC).  
 
Perfusions and Immunohistochemistry 
Animals were deeply anesthetized with sodium pentobarbital by intraperitoneal 
injection and then transcardially perfused with PBS followed by 4% paraformaldehyde 
(PFA) in PBS and prepared for free-floating immmunohistochemistry as described before 
(25). The following primary antibodies were used: rabbit anti-GAT-1 (1:250, Chemicon 
#AB1570), mouse anti-GAD67 (1:5000, Chemicon #MAB5406), mouse anti-AnkyrinG 
(1:500, NeuroMab #75-146), rat anti-somatostatin (1:200, Chemicon #MAB354), mouse 
anti-Reelin (1:250, MBL International #D223-3), rabbit anti-VIP (1:1000, ImmunoStar 
#20077), rabbit anti-nNOS (1:1000, ImmunoStar #24287), rabbit anti-calretinin (1:200, 
Chemicon #AB149), rabbit anti-GABA (1:2000, Sigma #A-2052), rabbit anti-Olig2 
(1:250, Millipore #AB9610), mouse anti-GFAP (1:500, Sigma #G3893), goat anti-
mCherry (1:500, Antibodies-Online #ABIN1440057), rabbit anti-NeuN (1:500, Millipore 
#ABN78), mouse anti-NeuN (1:500, Millipore # MAB377), goat anti-FGF13 (1:500, 
Santa Cruz #sc-16811), mouse anti-parvalbumin (1:1000, Sigma #P-3088), rabbit anti-
parvalbumin (1:5000, Swant #PV-25), goat anti-parvalbumin (1:500, Swant #PVG-214); 
chicken anti-parvalbumin (1:500, SySy #195 006), rabbit anti-DsRed (1:500, Clontech 
#632496), chicken anti-GFP (1:1000, Aves Lab #1020), rabbit anti-VGAT (1:1000, 
SYSY #131 002), mouse anti-GAD65 (1:500, Millipore #MAB351R), rabbit anti-GluD1 
(1:16000, kind gift from Ludovic Tricoire), mouse anti-Synaptotagmin-2 (1:250, ZFIN 
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#ZDB-ATB-081002-25), mouse anti-gephyrin (1:500, Synaptic Systems #147 011), 
guinea pig anti-ADAM22 (1:500, Synaptic Systems #317 005). 
 
Fluorescent In Situ Hybridization Histochemistry 
For dual-color fluorescent in situ hybridization combined with 
immunohistochemistry, mice were perfused and brains were fixed overnight in 4% PFA 
in PBS followed by cryoprotection in 30% sucrose-RNase free PBS and subsequent 
incubations as described before (25). The following DIG-labeled probes were used:  
Cbln4 Fw: TAG AAC CCG ACT TCT CCG TGA TG and Rv: GCG ATA GAG TAT 
TCG ATT TCC CACC; Lgi2 Fw: AGA TGA CAA ACT CCA CCG TCT and Rv: TAA 
AAC CCT TTG CTG TTC CAC; Pcdh18 Fw: TCC ACC TCG CTT CCA GAG G and 
Rv: GGA TCT GCC ACC CG CAG. The following primary antibodies were used: 
chicken anti-GFP (1:500, Aves Lab #1020), rabbit anti-parvalbumin (1:5000, Swant 
#PV-25), rat anti-somatostatin (1:50, Chemicon #MAB354). Dlx6aCre/+;Prox1-EGFP+/F 
(Jackson Laboratories #008199 and (50), respectively) as well as VIPCre/+;RCE (Jackson 
Laboratories #010908 and #32037, respectively) fate-mapped brains used for 
colocalizations with Cbln4 and Lgi2 mRNA were a gift from G. Fishell. 
 
Cell Culture and Transfection 
Cell lines. HEK293T cells were cultured in Dulbecco’s Modified Eagle’s medium 
supplemented with 10% fetal bovine serum, 2 mM glutamine, penicillin (50 units/ml) and 
streptomycin (50 g/ml). The cultures were incubated at 37°C in a humidified atmosphere 
containing 5% CO2. HEK293T cells were transfected using polyethylenimine (PEI, 
Sigma) at a 1:4 DNA:PEI ratio.  
 
Generation of AAV Expression Vectors 
The pDIO-DSE-mCherry-PSE-MCS was engineered as follows: (1) the sequence 
containing the distal (DSE) and proximal elements (PSE) of the U6 promoter spaced by 
the CDS for mCherry was amplified by PCR (primers: Fw-TTC GCT AGC GGA TCC 
GGA ATA AC and Rv-CCA GAG GTT GAT TGG TTT ATC AGGC); (2) the resulting 
PCR product was cloned into the pAAV-EF1a-DIO-mCherry vector (kindly provided by 
Prof. K. Deisseroth) and a TATA box was introduced in the U6 fragment (primers: Fw- 
TAT GCT TAC CGT AAC TTG AAA GTA TTT CGA TTT CTT GGG TTT ATA TAT 
CTT GTG GAA AGG ACG CGG TTT CCT AGG TTT AAA CTG and Rv- TAT GCT 
TAC CGT AAC TTG AAA GTA TTT CGA TTT CTT GGG TTT ATA TAT CTT GTG 
GAA AGG ACG CGG TTT CCT AGG TTT AAA CTG). The ssDNA primers to 
generate the shRNAs were obtained using the Block-it RNAi web tool (Thermo 
Scientific) and were as follows: shGFP ( Fw: CTA GAA ATC GCT GAT TTG TGT 
AGT CCC TGA CCC AGA CTA CAC AAA TCA GCG ATT TTT TTTG and Rv: AAT 
TCA AAA AGC CAC AAC GTC TAT ATC ATG GTG GGT CAG GCC ATG ATA 
TAG ACG TTG TGGC), shLacZ (Fw: cta gAA ATC GCT GAT TTG TGT AGT CCC 
TGA CCC AGA CTA CAC AAA TCA GCG ATT Ttt tttg and Rv: aat tca aaaa AAA 
TCG CTG ATT TGT GTA GTC TGG GTC AGG GAC TAC ACA AAT CAG CGA 
TTT), shCbln4 (shRNA1 Fw: aat tca aaaa AAA TCG CTG ATT TGT GTA GTC TGG 
GTC AGG GAC TAC ACA AAT CAG CGA TTT and Rv: AAT TCA AAA AGC AAC 
AAG ACT CGC ATC ATT TTG GGT CAG GAA ATG ATG CGA GTC TTG TTGC; 
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shRNA2 Fw: CTA GGC TCC TGT ACC TGG ACA AAG ACC TGA CCC ATC TTT 
GTC CAG GTA CAG GAG CTT TTTG and Rv: AAT TCA AAA AGC TCC TGT ACC 
TGG ACA AAG ATG GGT CAG GTC TTT GTC CAG GTA CAG GAGC; shRNA4 
Fw: CTA GGA CTC CAA GG GAT CAT CAT CTC CTG ACC CAA GAT GAT GAT 
CCC TTG GAG TCT TTT TG and Rv:  AAT TCA AAA AGA CTC CAA GGG ATC 
ATC ATC TTG GGT CAG GAG ATG ATG ATC CCT TGG AGTC), shLgi2 (shRNA1 
Fw: CTA GGC AGC TGC TAT TGC TGA ATT CCC TGA CCC AGA ATT CAG CAA 
TAG CAG CTG CTT TTTG and Rv: AAT TCA AAA AGC AGC TGC TAT TGC TGA 
ATT CTG GGT CAG GGA ATT CAG CAA TAG CAG CTGC; shRNA2 Fw: CTA 
GGG AGA AGA AAC TCA ACG AAG TCC TGA CCC AAC TTC GTT GAG TTT 
CTT CTC CTT TTTG and Rv: AAT TCA AAA AGG AGA AGA AAC TCA ACG 
AAG TTG GGT CAG GAC TTC GTT GAG TTT CTT CTCC; shRNA3 Fw: CTA GGG 
GAC CAC ATA GAA ATG AAT TCC TGA CCC AAA TTC ATT TCT ATG TGG 
TCC CTT TTTG and Rv: AAT TCA AAA AGG GAC CAC ATA GAA ATG AAT TTG 
GGT CAG GAA TTC ATT TCT ATG TGG TCCC; shRNA4 Fw: CTA GGC TCT CAC 
ATT TAC AAA TAC GCC TGA CCC ACG TAT TTG TAA ATG TGA GAG CTT 
TTTG and Rv: AAT TCA AAA AGC TCT CAC ATT TAC AAA TAC GTG GGT CAG 
GCG TAT TTG TAA ATG TGA GAGC; shRNA5 Fw: CTA GGC AGA ACA CCC 
TCT ACC TTT CCC TGA CCC AGA AAG GTA GAG GGT GTT CTG CTT TTTG 
and Rv: AAT TCA AAA AGC AGA ACA CCC TCT ACC TTT CTG GGT CAG GGA 
AAG GTA GAG GGT GTT CTGC), shFGF13 (shRNA2 Fw: CTA GGC ACT TAC 
ACT CTG TTT AAC CCC TGA CCC AGG TTA AAC AGA GTG TAA GTG CTT 
TTTG and Rv: AAT TCA AAA AGC ACT TAC ACT CTG TTT AAC CTG GGT CAG 
GGG TTA AAC AGA GTG TAA GTGC; shRNA4 Fw: CTA GGC AAT GAA CAG 
CGA GGG ATA CCC TGA CCC AGT ATC CCT CGC TGT TCA TTG CTT TTTG and 
Rv: AAT TCA AAA AGC AAT GAA CAG CGA GGG ATA CTG GGT CAG GGT 
ATC CCT CGC TGT TCA TTGC; shRNA6 Fw: CTA GGG CAA GAC CAG CTG 
CGA CAC CTG ACC CAT GTC GCA GCT GGT CTT GCC TTT TTG and Rv: AAT 
TCA AAA AGG CAA GAC CAG CTG CGA CAT GGG TCA GGT GTC GCA GCT 
GGT CTT GCC from (21)), shPcdh18 (shRNA1 Fw: CTA GGC ACT TTA GAT TTG 
CAC TTG CCC TCA CCC AGC AAG TGC AAA TCT AAA GTG CTT TTT G and Rv: 
AAT TCA AAA AGC ACT TTA GAT TTG CAC TTG CTG GGT GAG GGC AAG 
TGC AAA TCT AAA GTG C; shRNA2 Fw: CTA GGC AGC CTT CTT ACA CAA 
TAC ACC TCA CCC ATG TAT TGT GTA AGA AGG CTG CTT TTT and Rv: AAT 
TCA AAA AGC AGC CTT CTT ACA CAA TAC ATG GGT GAG GTG TAT TGT 
GTA AGA AGG CTG CG; shRNA3 Fw: CTA GGC TGT GTT GCT GGT TAT TAT 
GCC TCA CCC ACA TAA TAA CCA GCA ACA CAG CTT TTT G and Rv: AAT 
TCA AAA AGC TGT GTT GCT GGT TAT TAT GTG GGT GAG GCA TAA TAA 
CCA GCA ACA CAG C; shRNA4 Fw: CTA GGG GAG AAT TCC AGC AGC AAT 
GCC TCA CCC ACA TTG CTG CTG GAA TTC TCC CTT TTT G and Rv: AAT TCA 
AAA AGG GAG AAT TCC AGC AGC AAT GTG GGT GAG GCA TTG CTG CTG 
GAA TTC TCC C; shRNA5 Fw: CTA GGC ATT CTC ATC AGG GCC TTG ACC TCA 
CCC ATC AAG GCC CTG ATG AGA ATG CTT TTT G and Rv: AAT TCA AAA 
AGC ATT CTC ATC AGG GCC TTG ATG GGT GAG GTC AAG GCC CTG ATG 
AGA ATG C). To minimize the putative off-target effects of the shRNA, a miR-133 
derived loop sequence was used (51). The shRNAs targeting FGF13 (shRNA-2 and 
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shRNA4) were obtained from previous studies (21). Both shRNAs are designed to 
downregulate the expression of the two known isoforms of FGF13, Fgf13A and Fgf13B. 
For the rescue experiments, a triple vector containing the shRNAs, mCherry and the 
shRNA-resistant full-length proteins were generated. The coding sequences for Cbln4, 
Lgi2 and Fgf13 full-length were obtained from P30 mouse hippocampal cDNA and 
cloned into the pGEMT-easy vector (Promega). Fgf13A and Fgf13B isoforms were 
subcloned for the subsequent rescue experiments. The shRNA resistant proteins were 
designed and ordered via GeneArts (ThermoFisher) in order to have 5 synonymous 
mutations to each shRNA and a HA tag sequence. These DNA sequences were cloned in 
the pDIO-DSE-mCherry-PSE-MCS after adding a T2A sequence generating the pDIO-
DSE-mCherry-T2A-mutFull-length-PSE-MCS (shRNA) plasmid (Fig. S12).  
 
AAV Production and In Utero/Intracranial Injections 
AAV Production. HEK 293FT cells (ThermoScientific) were seeded on 15-cm plates 
and co-transfected with packaging plasmids AAV-ITR-2 genomic vectors (7.5μg), AAV-
Cap8 vector pDP8 (30 μg; PlasmidFactory GmbH, Germany, #pF478) or AAV-Cap DJ 
Rep-Cap vector (30 μg; Cell Biolabs, VPK-420-DJ) using PEI (Sigma) at a ratio 1:4 
(DNA:PEI). 72 hours post transfection, supernatants were incubated with Ammonium 
sulfate (65g/200ml supernatant) for 30 minutes on ice and centrifuged for 45 minutes at 
4000 RPM at 4°C. Transfected cells were harvested and lysed (150mM NaCl, 50mM Tris 
pH8.5), followed by three freeze-thaw cycles and Benzonase treatment (50U/ml; Sigma) 
for 1 hour at 37°C. Filtered AAVs (0.8 μm and 0.45 μm MCE filters) from supernatants 
and lysates were run on an Iodixanol gradient by ultracentrifugation (Vti50 rotor, 
Beckmann Coultier) at 50,000 RPM for 1 hour at 12°C. The 40% iodixanol fraction 
containing the AAVs was collected, concentrated using 100 kDa-MWCO Centricon plus-
20 and Centricon plus-2 (Merck-Millipore), aliquoted and stored at -80°C. The number of 
genomic copies was determined by qPCR using the following primers against the WPRE 
sequence: Fw: GGC ACT GAC AAT TCC GTG GT and Rv: CGC TGG ATT GAG 
GGC CGAA). AAVs with a titer equal or higher to 1011 genome copy/ml were used for 
in vivo injections. For down-regulation experiments, two shRNAs producing a good in 
vitro downregulation were used for each gene. The two shRNA plasmids were co-
transfected for AAV production in order to increase the downregulation efficiency. The 
AAV8-hSyn-FLEX-Chronos-GFP and AAV9-hSyn-eGFP were acquired from the Penn 
Vector Core, with a titer of 4.60 x 1012 genome copy/ml and 8.88 x 1012, respectively. 
Intracranial injections. For intracranial injections, P2 (Nkx2-1CreER/+ and PVCre/+) or 
P3 (Lhx6Cre/+ and SstCre/+) pups were anesthetized with isoflurane and mounted on a 
stereotactic frame using a 3D printed isoflurane mask. Unilateral or bilateral stereotaxic 
injections of the Cre-dependent viruses at rate of 100 nl/minute followed by 2 additional 
minutes to allow diffusion were carried out as follows. For SST interneuron experiments: 
AAV8-shCbln4-mCherry, AAV8-shCbln4-mCherry-T2A-mCbln4-HA or AAV8-shLacZ-
mCherry or dual injections with AAV8-shCbln4-mCherry and AAV8-Chronos-GFP were 
injected in the somatosensory cortex (anteroposterior –2.5/ -2.7 mm; mediolateral 
+2.1/2.3 mm; dorsoventral –0.5 and –0.2 mm relative to Bregma) of SstCre/+ mice. For PV 
basket cell experiments: AAV8-shLgi2-mCherry, AAV8-shLgi2-mCherry-T2A-mLgi2-HA 
or AAV8-shLacZ-mCherry were injected in the somatosensory cortex (anteroposterior –
2.5/ -2.7 mm; mediolateral +2.1/ 2.3 mm; dorsoventral –0.5 relative to Bregma) of 
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Lhx6Cre/+ mice. For chandelier cells experiments: AAV8-shFgf13-mCherry, AAV8-
shFgf13-mCherry-T2A-mFgf13A-Flag, AAV8-shFgf13-mCherry-T2A-mFgf13B-HA or 
AAV8-shLacZ-mCherry were injected in the medial prefrontal cortex (anteroposterior 
−0.6 mm; mediolateral +0.2 mm; dorsoventral −0.4 and −0.8 mm relative to Bregma) in 
Nkx2-1CreER/+ or PVCre/+. All viruses used for injection were serotype 8 with the exception 
of the experiments performed with SstCre/+ where data from mice injected with AAV8 or 
AAV-DJ 2 were pooled because no difference was found between them. 
Over- and ectopic- Cbln4 expression experiments were performed injecting a Cre-
dependent virus expressing Cbln4-HA in SstCre/+, PVCre/+ and Nkx2-1CreER/+ mice. Dual 
injections of AAV9-hSyn-eGFP together with AAV8-DIO-mCbln4-HA allowed the 
labeling of the pyramidal cells for the quantification of PV somatic and chandelier inputs. 
In utero injections. In utero injections for morphological reconstructions were 
performed as described previously (37). Briefly, we obtained isolated cells by injecting 1 
μL of AAVs diluted 1:30 in PBS with FastGreen 0.5%, into the telencephalic lateral 
ventricle of E14.5 SstCre/+ or E15.5 Lhx6Cre/+ embryos. Pregnant females were deeply 
anesthetized with isoflurane (5% induction, 2% maintenance), the abdominal cavity was 
cut opened and the uterus exposed making the embryos accessible. After injection, the 
uterus was placed back in the abdominal cavity, the incision was sutured and 
buprenorphine 0.1 mg/kg was used for analgesia. 
 
Western blot and co-immunoprecipitation 
For western blot analysis, HEK293T were rinsed with 1x ice-cold PBS. Samples 
were homogenized in lysis buffer containing 25 mM Tris-HCl pH 8, 50mM NaCl, 1% 
Triton X-100, 0.5% sodium deoxycholate, 0.001 % SDS and protease inhibitor cocktail 
(cOmplete Mini, Roche). Samples were resolved by SDS-PAGE and transferred onto 
PVDF membranes. Membranes were blocked with 5%  Blotting-Grade Blocker (Bio-
Rad, #1706404) in TBST (20mM Tris-HCl pH7.5, 150mM NaCl and 0.1% Tween20) for 
1 hour and probed with the following primary antibodies overnight at 4°C: rabbit anti-
actin (1:1000, Sigma #A2066), mouse anti-HA (1:500, Thermo Fisher #26183), rabbit 
anti-GluD1 (1:5000, kind gift from Ludovic Tricoire), guinea pig anti-ADAM22 (1:1000, 
Synaptic Systems #317 005). After incubation with HRP-conjugated secondary 
antibodies, protein levels were visualized by chemiluminescence. Blots were scanned 
using a LI-COR Odyssey® Fc Imaging System or a ChemiDoc (Bio-Rad). 
For co-immunoprecipitation (co-IP) experiments, 900,000 HEK cells were 
transfected with 4 μg of Cre expressing plasmid and 4 μg of Cre-dependent plasmid 
expressing Cbln4-HA, Lgi2-HA or mCherry (8 μg of total DNA) using Lipofectamine 
2000 Transfection Reagent (Thermo Fisher, 12566014) according to manufacturer's 
instructions. Supernatants and lysates were collected 4 days after transfection and mixed 
with 600 μg of cortical homogenates from P30 mice. The mix was then diluted in 1 ml of 
Co-IP buffer (0.3M sucrose, 10 mM Tris-HCl pH 8, 10 mM NaCl, 3 mM MgCl2, 1% 
NP-40, 5% glycerol and protease inhibitor cocktail) and subsequently incubated with 30 
μl of anti-HA magnetic beads (Thermo Fisher, 88836) at 4°C for 2 hours (preclearing). 
The precleared mix was then subsequently incubated overnight at 4°C with 30 μl of anti-
HA magnetic beads (Thermo Fisher, 88836). After overnight incubation at 4°C with 
gentle rotation, the beads were rinsed six times with Co-IP buffer. Immune complexes 
were then analyzed by western blot. Since in most experiments both Adam22 and GluD1 
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appeared to bind the HA-beads despite preclearing and a high number of washes, the co-
IP success was defined as such when the fold change between the amount of 
immunoprecipitated partner in the IP containing the protein of interest (Lgi2 or Cbln4) 
was at least 1.5 folds higher than that found in the IP without the protein of interest. 
 
Image acquisition and analysis 
For imaging analysis, tissue samples were imaged on an inverted Leica TCS-SP8 
confocal maintaining same laser power, photomultiplier gain, pinhole, and detection filter 
settings (1024x1024 resolution, 8 bits or 16 bits for fluorescence intensity 
quantifications). Cell co-localization analyses were carried out using confocal image 
stacks (40X oil immersion objective, 1.4 NA, 0.2 μm step size) and analyzed using a 
custom macro in Fiji (ImageJ) software. Counting of the number of interneurons per layer 
and the cell co-localization analyses based on in situ hybridizations were performed 
manually. Fluorescence intensity analysis in Figure 2 was performed in the prefrontal 
cortex as described before (25). For synaptic analysis, confocal image stacks were taken 
(100X oil immersion objective, 1.44 NA, 2.2 digital zoom, 0.2 μm step size) and 
analyzed at P28-P30 with IMARIS 7.5.2 software for all experiments, except for Fig. S1, 
S13 and S19 where Image J was used as described before (25). 
For the analysis of synaptic inputs made by the SST cells, we analyzed synapses in 
layer I, which contains the apical tufts of mainly layer V but also (less abundant) layer 
II/III pyramidal neurons (52). For PV+ basket cells synapses, because Lgi2 is more 
expressed in lower layers, we focused our analysis on nearby pyramidal cells located in 
layer V. For chandelier synapse analysis, because we mainly label chandelier cells 
located in layer II, we analyzed axo-axonic synapses onto nearby pyramidal cells, i.e. 
located in layer II/III. 
For all analyses performed in Imaris, threshold values were calculated and applied 
in the same way for all brains or cells within each experiment (i.e. for all brains/cells 
belonging to both control and knockdown/overexpression). Unless otherwise stated, 
threshold values were calculated individually for each brain using the “above automatic 
threshold” tool in Imaris. For the majority of experiments, an average threshold among 
these individual values was computed and applied to all images. When >2 individual 
threshold values were more than 5 “Quality” units apart, the individual threshold values 
were used. Such values were automatically established (“above automatic threshold” 
tool) in Imaris in the non-injected hemisphere or in the injected hemisphere for brains 
that had bilateral injections. 
For the analysis of synaptic inputs made by the SST cells, we quantified the density 
of synapses within the Somatostatin axon labeled with mCherry. These axons were 
reconstructed with the “create surface” tool. Briefly, mCherry+ axons included within the 
tissue sections were isolated in three dimensions. Three-dimensional isosurfaces were 
created using the “create surface” tool and volume was quantified automatically. An 
automatic threshold was selected to include as much of the axon as possible while 
excluding any background and a 0.02 μm3 size filter was applied. Then, we used 
GAD65+ as a presynaptic marker, and applied the “spot” tool to detect the GAD65+ 
boutons within the surface using a threshold automatically established in Imaris (“above 
automatic threshold” tool) and a spot diameter of 0.6 μm. These boutons were quantified 
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as synapses when they were colocalizing with Gephyrin+ boutons (spots above automatic 
threshold, diameter of 0.3 μm).  
For the analysis of the PV cell outputs, we analyzed the Syt2+ somatic boutons 
within mCherry+ terminals contacting the NeuN+ soma of putative pyramidal cells. 
mCherry+ axons were automatically reconstructed using the “create surface” tool and 
NeuN+ somata were manually reconstructed using the “draw surface” tool. Syt2+ spots 
(spot diameter of 0.8 μm) within the surface of mCherry+ axons were considered PV 
synaptic terminals. Then, we used the tool “spots close to surface” (ImarisXT extension) 
to filter the spots located at 0.4 μm from the NeuN surface. Somatic Syt2+ boutons from 
infected cells were identified using “Split spots into surface” tool. Since the number of 
double-positive mCherry+Syt2+ boutons depends on the infection efficiency, we 
normalized bouton density to the number of infected PV+ cells in the area.  
For the analysis of chandelier cells, the axon initial segment (AIS, labeled with 
AnkyrinG) was reconstructed with the “create surface” tool as described above. A size 
filter was applied with the minimum size being related to the volume of the AIS. For 
bouton density, the chandelier presynaptic boutons were detected with the “spot” tool 
using a spot diameter of 0.7 μm and a threshold was manually selected to accurately 
detect as many spots as possible without creating artifacts (i.e. only the synaptic 
varicosities within a cartridge would be detected). The radius of the spot was used as a 
threshold distance to define the contact with the AIS and the “Find spots close to surface” 
tool (ImarisXT extension) was used to count the number of presynaptic boutons (“spots”) 
that were contacting the surface of the AIS. 
A cartridge was defined as such when at least 3 consecutive presynaptic boutons 
were found on the same chandelier axonal segment. For each cartridge, we measured 
length, number of boutons per cartridge, number of AISs contacted by one cartridge and 
the ‘distance to closest cartridge’ parameter. Cartridge length was quantified by tracing a 
line that joined all consecutive varicosities found on each cartridge and automatically 
measuring its length. The number of boutons in each cartridge was determined by 
counting the number of varicosities found in the entire length of each cartridge. The 
number of AISs contacted by one cartridge was assessed by calculating the total number 
of AISs contacted by one cartridge (with ‘cartridge’ and ‘contact’ defined as above) 
within the field of view. The ‘distance to closest cartridge’ indicates the average distance 
between each cartridge and the cartridge that is closest to it. This parameter is considered 
diagnostic of the overall density of the cartridges in a given volume and was used as a 
proxy to estimate the density of the chandelier arbor (53). 
Note that we used two different Cre drivers to downregulate Fgf13 in chandelier 
cells. First, Fgf13 was downregulated early using Nkx2-1CreER/+. Since Fgf13 
downregulation resulted in both axonal disorganization and synaptic loss, we could not 
rule out that the observed synaptic phenotype was merely a consequence of the 
disorganized chandelier axonal arborization rather than a deficit in synapse formation 
(e.g. since each AIS is innervated by more than one cartridge (54) and the axonal arbor is 
less dense upon Fgf13 downregulation, the resulting average synapse density onto the 
AIS may be correspondingly scaled down). Then, we took advantage of the PVCre/+ line, 
which turned on the expression of Cre at later stages of development (after P14) and 
therefore downregulated Fgf13 when the axon was almost fully developed. This approach 
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has also been used by others in the past to tell apart axonal and synaptic phenotypes in 
chandelier cells (55).  
The analysis of dendritic synapses made by PV+ basket or chandelier cells was 
performed as detailed above with the exception that the target dendrites (labeled by 
AAV9-hSyn-eGFP viral injection) were reconstructed with the “create surface” tool.  
The analysis of SST+ synapses onto the proximal and distal dendrites shown in 
Figure S13 was performed as follows: single focal planes containing consecutive 
dendritic segments of a total length ≤ 10 μm were analyzed using a custom Image J 
macro similarly to what described before (25). Briefly, processing of all channels 
included background, subtraction, gaussian blurring, smoothing and contrast 
enhancement. All single channel images were converted to RGB. For the pyramidal cell 
dendrite, a color threshold was selected to identify the dendritic surface. The border of 
the dendrite was manually drawn to automatically calculate its area and create a mask 
with the dendrite only. For the mCherry+ or GAD65+ presynaptic boutons, a color 
threshold was selected to include as many putative synapses as possible while excluding 
any background. The “Analyze Particles” (size 0.20-infinity, circularity 0.00-1.00) tool 
was applied and a mask was generated. A merged image from all masks was created. 
Presynaptic boutons (mCherry+GAD65+) were defined as such when at least 50% of the 
signal from the two channels was overlapping. Contacts (mCherry+ terminals or 
mCherry+GAD65+ boutons) were defined as such when they were located outside the 
perimeter border but had ≥ 1 pixel colocalizing with the mask of the dendrite. For 
dendritic segments shorter than 10 μm, data from consecutive focal planes were analyzed 
until a total 10 μm length was reached. Data were collected as density (number of 
mCherry+GAD65+ presynaptic boutons or mCherry contacts per unit of dendritic 
surface) and the density data from each segment were used to generated cumulative plots 
(Fig. S13B and E). Data from segments within 40 μm from the soma were used to 
compute the average density for the proximal dendrites whereas data from segments 
located further than 40 μm were pooled to compute the average density onto the distal 
dendrites (Fig. S13 C and F). For the linear regression analysis in Fig S13D and G, the 
average density in each segment (segment length 10 μm, total length 100 μm) was 
computed for each cell and the results were used to perform the linear regression 
analysis. 
For the analysis of PV+ basket synapses using Nkx2-1CreER/+ in Figure S17A (right 
bar graph), mCherry+PV+ cells were identified and their axons were followed and 
imaged. Imaris reconstruction was performed as described above and, to exclude axons 
belonging to other cells, only axons making at least one Sty2+Gephyrin+ synapse were 
used to compute the volume of the presynaptic axon. 
For the synaptic colocalization graphs in Figure S19, a similar custom Image J 
macro was used with the exception that the output was the fraction of colocalizing 
particles. The synaptic profile plots in Figure S19 were generated using ImageJ as 
follows: a line (perpendicular to the synaptic cleft) was drawn starting just before the 
presynaptic site (x=0, to be able to obtain the background level) until slightly after the 
end of the postsynaptic cluster and the command “plot profile” (under “Analyze”) was 
used in “live mode” in such a way that the grey values for each channel were 
automatically computed along the line. The analysis performed in Figure S19 was 
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focused on Cbln4 and Lgi2 because these were the proteins for which a putative trans-
synaptic partner had been shown. 
 
Reconstruction and analysis of morphology 
Infected mCherry+ isolated neurons were stained and imaged on an Apotome.2 
(Zeiss) maintaining the same settings (1024x1024 resolution, 8 bits) and using a 20X 
objective (1.4 NA, 0.8 μm step size). The morphological evaluation was focused on 
Martinotti and PV+ basket cells located in layer V, since the synaptic analysis was mostly 
performed on the output of layer V interneurons (see Image acquisition and analysis 
section for synaptic analysis). The neuron’s processes were traced automatically and 
quantified using a modification of a custom Matlab script described before (56). 
 
In vitro Patch-Clamp Recordings 
Slice Preparation. Mice (P28-P50) were transcardially perfused with ice-cold 
NMDG (57) cutting solution (in mM: 93 NMDG, KCl 2.5, NaH2PO4 1.2, NaHCO3 30, 
HEPES 20, Glucose 25, Sodium Ascorbate 5, Thiourea 2, Sodium Pyruvate 3, MgSO4 
10, CaCl2 0.5). The brain was quickly removed and slices cut under the same solution as 
used for perfusion. Parasagittal slices were cut by making an incision on the right (non-
injected) hemisphere, angled 10-15 degrees with the midline (towards lateral side, away 
from experimenter). The brain was glued to the stage on this cut surface and 300 μm 
slices were cut using a vibratome (Leica). Slices were transferred to a heated chamber (34 
C°) containing cutting solution, where they underwent recovery for either 5 (current-
clamp recordings) or 12 minutes (voltage-clamp recordings). Slices were then moved to 
an incubation chamber containing room-temperature, oxygenated holding solution (NaCl 
92, KCl 2.5, NaH2PO4 1.2, NaHCO3 30, HEPES 20, Glucose 25, Sodium Ascorbate 5, 
Thiourea 2, Sodium Pyruvate 3, MgSO4 2, CaCl2 2), where they remained for an 
additional 40 minutes, and throughout the day, before being individually transferred to 
the recording chamber for experiments. 
Experimental conditions. All recordings were carried out at 32-34 C°. Before 
recording, slices were quickly screened for infection with the virus, and slices peripheral 
to the main area of infection were discarded. In most cases, 3 slices with strong and 
consistent infections were kept per animal. Care was taken to record from regions with 
dense infection, as visualized with infrared-differential interference optics (Hamamatsu 
camera controller) and fluorescence illumination (Cool Led 473nm) through a 10x or 40x 
water-immersion objective (Olympus). All neurons were recorded in S1 barrel field layer 
5 in artificial cerebrospinal fluid (NaCl 127, KCl 2.5, MgSO4 1.298, NaH2PO4 0.625, 
NaHCO3 26, Glucose 13, CaCl2 2). 
Pipettes were pulled from borosilicate glass (1.5 mm outer diameter x 0.86 mm 
inner diameter; Harvard Apparatus) on a vertical Narishige PC10 puller to obtain a tip 
resistance of 4-6 MΩ. For voltage-clamp recordings from pyramidal cells, Cesium 
Methanesulfonate solution was used (Cesium Methanesulfonate 135, KCl 8, HEPES 10, 
Mg-ATP 0.4, Na2-ATP 2.0, EGTA 0.5, Na-GTP 0.64, Qx-314 Chloride 5), whereas for 
current-clamp recordings from SST+ interneurons Potassium Gluconate solution was 
employed (Potassium Gluconate 130, KCl 5, HEPES 10, MgCl2 2, di-sodium 
phosphocreatinine 10, Na2-ATP 2, Na-GTP 0.64). For any experiment, only cells with 
access resistance < 20MΩ were accepted. The experimental protocol deployed per cell 
 
 
16 
 
lasted 10-20 minutes. Access resistance was monitored throughout using seal tests and 
any cells where access resistance deteriorated and increased above 30 MΩ were 
discarded. For pyramidal recordings, after breakthrough, a period of 3-5 minutes was 
allowed, for dialysis of the solution into the neuron. During this period, access resistance 
was monitored and improved if required. Prior to recording, voltage-clamped cells were 
held at -65 mV and slowly depolarised to an experimental holding potential of +40 mV, 
chosen to increase the driving force for chloride in order to enable easier detection of 
GABAergic input onto dendrites of pyramidal neurons. Data were filtered on-line at 2 
kHz, and acquired at a 50 kHz sampling rate using a MultiClamp 700B amplifier and 
Digidata 1440 digitiser (Axon Instruments). 
Optogenetics. All experiments were conducted under wide-field photostimulation 
(58) through a 40x water-immersion objective. Measurements of irradiance were taken 
regularly prior to beginning experiments with a power meter mounted underneath the 
recording chamber’s fluid-filled coverslip (without a slice). The recorded neuron was 
centred in the field of view. A 473nm LED was triggered to deliver a square-shaped pulse 
of 1 ms illumination at irradiance values of: 21.2, 17.7, 13.6, 9.3, 4.4, 2.0, 0.9 and 0.2 
mW/mm2. For every cell and irradiance value, we recorded 10 trials of photostimulation, 
which was delivered every 2 seconds. Glutamate receptors were blocked with 40µM D-
APV and 40µM CNQX. For minimal stimulation experiments2, irradiance was 
systematically lowered in small steps (0.02-0.05 mW/mm2) until stimuli no longer 
elicited IPSCs in the expected response window. At this point, irradiance was increased 
stepwise until a mixture of failures and events of reliable amplitude and latency was 
observed. Once minimal irradiance was established, 50 trials of minimal stimulation were 
acquired per cell. There were no statistically significant differences in failure rate 
between the Control (66.7 ± 3.5%) and Knockdown (71.0 ± 2.4%) groups (p = 0.3224, t = 
1.0, df = 34, Student’s t-test), indicating pre-synaptic SST neurons were similarly 
engaged by photostimulation. 
Data Analysis. The time window of optogenetically-evoked spiking was determined 
from recordings of SST+ interneurons expressing ChR2 in Control and Knockdown 
groups. At the highest irradiance used, latency to spike peak (relative to photostimulus 
onset) was 1.99 ± 0.54 ms and 2.28 ± 0.38 ms for respectively Control and Knockdown 
groups (no statistically significant difference; p = 0.1932, Mann-Whitney U = 106). For 
the lowest intensity that reliably elicited spikes (0.9 mW/mm2), these values were 4.05 ± 
0.62 ms and 4.70 ± 0.59 ms (no statistically significant difference; p = 0.2939, Mann-
Whitney U = 86). To ensure we captured IPSCs potentially occurring in distal dendrites, 
our even detection window encompassed the period of 2-20 ms after photostimulus onset. 
Within this window, we manually detected, extracted and analysed the earliest-occurring 
IPSC using Minianalysis (Synaptosoft). Optogenetically-evoked IPSCs were clearly 
time-locked and showed little trial-to-trial variability, making their detection and 
separation from spontaneous events straightforward, when aligning recording traces to 
photostimulus onset (see Fig. 4 for example traces). IPSC peak amplitude, peak time and 
10-90 rise time were averaged across the 10 sweeps at each irradiance per cell. IPSC 
onset time was approximated by subtracting 10-90 rise time from peak time. Average 
values per cell were then condensed into a grand average per group. 
For minimal stimulation experiments, the same procedure was applied to obtain 
event detection windows. Latency to spike was 11.1 ± 0.64 ms and 12.4 ± 0.74 ms for 
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Control and Knockdown groups respectively (no statistically significant difference; p = 
0.396, Mann-Whitney U = 121). We therefore used an IPSC detection window of 10-30 
ms after stimulus onset. IPSCs were detected manually as outlined above. Since minimal 
stimulation IPSCs are lower amplitude and occur under a regime of mixed successes and 
failures, distinction from spontaneously-occurring events is challenging. Therefore, for 
minimal stimulation experiments we extracted and analysed any IPSC event occurring 
within the detection window. Keeping this window narrow helped us lower the 
probability that spontaneous events “contaminated” our analysis. 
Intrinsic properties of SST+ interneurons were measured rapidly after obtaining 
whole-cell configuration. A series of depolarizing or hyperpolarizing 500 milliseconds 
current steps were used at 0.5 Hz. Resting membrane potentials were measured just after 
patched membranes were ruptured by suction. Input resistance and membrane time 
constants were determined by passing hyperpolarizing current pulses inducing voltage 
shifts of 5-15 mV negative to resting membrane potential. Time constants were measured 
by fitting voltage responses with a single exponential function. Action potential (AP) 
threshold was determined as the voltage at which the first derivative of voltage over time 
exceeded 20 mV/ms. AP widths at half amplitude were measured for spikes elicited by 
depolarizing current pulses of threshold strength. Rheobase was determined by initially 
injecting positive current generating near-threshold 15-25 mV depolarizations and 
subsequently applying 1 pA current steps until APs were elicited. Rheobase was 
considered to have been reached once three such steps consecutively produced an AP, 
with the lowest value of the AP-generating injected currents used. Delay to first AP was 
measured during the same procedure, as the time elapsed between onset of current 
injection and AP threshold and was calculated from the average of 4 repetitions of this 
procedure. AP height was calculated as the difference in membrane potential between AP 
threshold and the peak. Afterhyperpolarisation (AhP) amplitude was defined as the 
difference between AP threshold and the most negative potential attained within 5 
milliseconds of AP threshold. AhP time was defined as the time elapsed between this 
point and AP threshold. Maximum firing frequency and input-output curves were 
obtained by injecting steps of 50-100 pA current. AP frequency adaptation was calculated 
as the percent change in spike frequency during the last 100 milliseconds of the spike 
train compared to the first 100 milliseconds. 
 
Statistical analysis 
All statistical analyses were performed using GraphPad Prism 6 (GraphPad 
Softwares) or SPSS (IBM Corp) softwares. Normality was assessed using the Shapiro-
Wilk normality test. Unless otherwise stated, parametric data were analyzed by t-test or 
one-way ANOVA followed by Holm-Sidak or Tukey post hoc analysis for comparisons 
of multiple samples. Non-parametric data were analyzed by the Mann-Whitney rank sum 
test or Kruskal-Wallis one-way analysis of variance on ranks followed by Holm-Sidak or 
Dunn post hoc analysis for comparisons of multiple samples. Probability distributions 
were compared using the Kolmogorov-Smirnov test. P values <0.05 were considered 
statistically significant. Data are presented as mean ± SEM. 
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Fig. S1. Development of different types of inhibitory synapses over time. 
(A to C) Schematic, density, representative image and corresponding thresholded mask 
used for quantification of GFP+ GAD65+ presynaptic boutons per unit of area at 
different stages of early postnatal development in layer I of the mouse somatosensory 
cortex where the majority of dendritic inhibitory synapses are made by Martinotti cells on 
the terminal tuft dendrites of pyramidal cells (n ≥ 4 SST-Cre::RCE mice for each stage). 
(D to F) Schematic, density, representative image and corresponding thresholded mask 
used for quantification of Syt2+ presynaptic boutons around the soma of NeuN+ 
pyramidal neurons in layer II/III of the mouse somatosensory cortex at different stages of 
early postnatal development (n ≥ 6 mice for each stage). (G to I) Schematic, density, 
representative image and corresponding thresholded mask used for quantification of 
GAT1+ presynaptic boutons contacting the postsynaptic axonal initial segment (AIS) 
scaffold protein Ankyrin G (AnkG) at different stages of early postnatal development in 
layer II/III of the mouse prefrontal cortex (n ≥ 5 mice for each stage). *p<0.05, **p<0.01, 
***p<0.001, One-way ANOVA followed by Tukey’s multiple comparisons test.. Scale 
bar equal 2 μm (B, C, E, F) and 1 μm (H and I). 
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Fig. S2. Validation of RNA-seq experiments. 
(A) Diagram illustrating the RNA-seq analysis workflow. (B) Bar graph showing a 
similar dispersion of total mRNA expression in the different cell populations. (C) Similar 
dispersion patterns of counts in the different cell populations and stages. (D) The 
distributions of FPKM scores are comparable across samples. (E) The squared coefficient 
of variation shows low cross-replicate variability between cell populations and stages. (F) 
Unsupervised hierarchical clustering based on the Jensen-Shannon (JS) distance of the 
complete RNA-seq transcriptome data reveals low distance among replicates and higher 
distance across cell types. (G) Principal component (PC) analysis on individual gene 
levels (FPKM) indicates that cell-type and developmental stage were the greater sources 
of variability in gene expression.  
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Fig. S3. Further validation of the RNA-seq and gene ontology analysis of 
interneuron-subtype enriched genes at P10.  
(A) Analysis of the expression of well-known cell type-specific genes verifies that each 
cell-type has minimal contamination with other subtypes. (B) The expression of well-
known synaptogenic genes increases between the selected developmental stages, 
confirming the suitability of the transcriptome data to identify genes that regulate synapse 
development. Note that the genes in (B) are also involved in synapse development and 
exhibit a similar increase in their expression between the two selected stages. (C) 
Heatmap showing the number of differentially expressed genes between cell-types at 
different stages using a False Discovery Rate (FDR) < 0.05. (D) Gene ontology (GO, 
cellular component category) enrichment analysis performed using the lists of P10 
interneuron subtype-specific genes. 
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Fig. S4. Expression of interneuron subtype-specific genes during development in 
adult scRNAseq dataset from Tasic et al. 2016 (1). 
(A-C) Violin plots representing the distribution of mRNA expression levels (RPKM) of 
candidate genes for developing SST+ (A), PV+ basket (B) and chandelier cells (C). Note 
that genes are displayed in alphabetical order. (D) Bar graph illustrating the relative 
proportion of developmentally-regulated genes that are enriched in the corresponding 
clusters of SST+ or PV+ cell types identified in Tasic et al. 2016 (1). The coloured bars 
follow the colour code for the developing interneuron subtypes. The colours for both 
basket and chandelier cells are pooled into the genes enriched in PV+ clusters. The grey 
bars correspond to the percentages of genes in each developing interneuron population 
that are not enriched in any cell type from the adult dataset. 
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Fig. S5. Expression of interneuron subtype-specific genes during development in 
adult scRNAseq dataset from Paul et al. 2017 (6). 
(A-C) Violin plots representing the distribution of mRNA expression levels (RPKM) of 
candidate genes for developing SST+ (A), PV+ basket (B) and chandelier cells (C). Note 
that genes are displayed in alphabetical order. (D) Bar graph illustrating the relative 
proportion of developmentally-regulated genes that are enriched in the corresponding cell 
types–Martinotti cells (MNC), PV+ basket cells (PVC), and chandelier cells (CHC)–
sorted in Paul et al. 2017 (6). The coloured bars follow the colour code for the developing 
interneuron subtypes. The grey bars correspond to the percentages of genes in each 
developing interneuron population that are not enriched in any cell type from the adult 
dataset. 
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Fig. S6. Expression of interneuron subtype-specific genes during development in 
adult scRNAseq dataset from Zeisel et al. 2015 (5). 
(A-C) Violin plots representing the distribution of mRNA expression levels 
(molecules/cell) of candidate genes for developing SST+ (A), PV+ basket (B) and 
chandelier cells (C). Note that genes are displayed in alphabetical order. (D) Bar graph 
illustrating the relative proportion of developmentally-regulated genes that are enriched 
in the corresponding clusters of SST+ or PV+ cell types identified in Zeisel et al. 2015 
(5). The coloured bars follow the colour code for the developing interneuron subtypes. 
The colours for both basket and chandelier cells are pooled into the genes enriched in the 
PV+ clusters (Int. 3). The grey bars correspond to the percentages of genes in each 
developing interneuron population that are not enriched in any cell type from the adult 
dataset. 
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Fig. S7. Matching interneuron subtype-specific and pyramidal cell gene/protein-
pairs. 
(A-C) Cell-specific candidate synaptic molecules expressed in SST+ (A), PV+ basket (B) 
and chandelier cells (C) ranked based on the presence and specificity of their putative 
postsynaptic partners in pyramidal neurons (see Table S4 for details). Note that this 
analysis relies on known protein-protein interactions and, therefore, proteins for which a 
partner has not yet been identified have an artificially biased lower ranking. 
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Fig. S8. Differential gene expression and dynamics of protein families related to 
synapse formation and function in different interneuron subtypes. 
(A) Ternary diagrams for different protein families: contactins (Cntn), contactin-
associated proteins (Cntnap), immunoglobulin superfamily members (Igsf), cadherins 
(Cdh), non-clustered protocadherins (Pcdh), immunoglobulin-like cell adhesion 
molecules (IgCAM), semaphorins (Sema) and protein tyrosine phosphatase receptors 
(PTPR). The dot size corresponds to the maximum level of expression of each gene 
(log2FPKM+1) in the three subpopulations at P5/8 or P10. Differentially expressed genes 
are represented with solid outlines (FDR < 0.05). Enriched genes are color-coded for a 
particular interneuron population based on the cell type specificity score (>0.45). Gray 
colors were used for genes that did not show enrichment for any interneuron subtype. 
Genes highlighted in bold showed a 2-fold or higher upregulation in their expression 
levels (FPKM) between both developmental stages. 
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Fig. S9. Characterization of Lgals1 and Hapln1 expression. 
(A-B) Representative image showing the colocalization of Lgals1 with PV and SST. SST 
cells were fated-mapped and labeled using SSTCre/+;RCE. Scale bars equal to 50 μm. (C) 
Percentage of PV+ cells that express Lgals1 and of Lgals1+ cells that express PV. 
Percentage of SST+ cells that express Lgals1 and of Lgals1+ cells that express SST. (D-
I) Representative images showing the colocalization of Hapln1 mRNA with GABA, 
Olig2, SST, chandelier cells (Nkx2-1CreER/+;RCE), PV and Reelin at P30 in the mouse 
prefrontal cortex (PFC). Scale bars equal to 20 μm. (J) Percentage of Hapln1+ cells that 
express GABA at P30 in the mouse prefrontal cortex (PFC, n = 3 mice). Note that all 
Hapln1+ cells are GABAergic. (K) Percentage of chandelier cells in the indicated 
regions/layers (labeled upon P2 Tamoxifen induction in Nkx2-1CreER/+;RCE mice) that 
express Hapln1 at P30 (n = 3 mice). Note the increase in the percentage of colocalizing 
cells in layers/regions enriched in chandelier cells. One-way ANOVA (p<0.001), 
followed by Holm Sidak’s multiple comparisons test (p<0.001 for all comparisons). (L) 
Fraction of PV+ cells that express Hapln1 in the prefrontal cortex at P30  (n = 3 mice). 
Note the low colocalization, consistent with expression in some PV+ chandelier but not 
basket cells. (M) Identification of cell types expressing Hapln1 in the prefrontal cortex 
(PFC) at P30 (n = 3 mice per condition). GFP+ cells (both PV+ and PV-) are labeled 
chandelier cells and RELN+SST- cells are neurogliaform cells. 
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Fig. S10. Characterization of Cbln4, Lgi2 and Fgf13 expression in interneuron 
subtypes during development. 
(A) Percentage of Cbln4+ cells (detected by in situ hybridization) that express SST in the 
indicated layers of the mouse somatosensory cortex at P10 and P30. (B) Percentage of 
SST+ cells that express Cbln4 in the indicated layers of the mouse somatosensory cortex 
at P10 and P30. (C) Percentage of Cbln4+ cells that express PV at P30 (left bar graph) 
and percentage of Cbln4+ cells that are Prox1+ (fate-mapped using Dlx6aCre/+;Prox1-
eGFP+/F mice and analyzed at P60) or VIP+ (fate-mapped using VIPCre/+;RCE mice and 
analyzed at P25) interneurons derived from the caudal ganglionic eminence (CGE INs, 
right bar graph). (D) Percentage of Lgi2+ cells (detected by in situ hybridization) that are 
PV+ in the indicated layers of the mouse somatosensory cortex at P10 
(Lhx6Cre;RCE+SST- cells) and P30 (PV+ cells). (E) Percentage of PV+ cells that 
express Lgi2 in the indicated layers of the mouse somatosensory cortex at P10 
(Lhx6Cre;RCE+SST- cells) and P30 (PV+ cells). (F) Percentage of Lgi2+ cells that 
express SST at P30 (left bar graph) and percentage of Lgi2+ cells that are Prox1+ (fate-
mapped using Dlx6aCre/+;Prox1-eGFP+/F mice and analyzed at P60) or VIP+ (fate-
mapped using VIPCre/+;RCE mice and analyzed at P25) interneurons derived from the 
caudal ganglionic eminence (CGE INs, right bar graph). (G) Analysis of the identity of 
FGF13+ cells by colocalizing FGF13 with different markers at P10 and P30 in the mouse 
prefrontal cortex. All FGF13+ cells are GABAergic but they are negative for all markers 
except Reelin and PV (note that the colocalization with PV could not be assessed at P10 
due to its late expression). This analysis, together with the observation that all labeled 
chandelier cells express FGF13 (Fig. 2E), is the base for the estimation provided in 
Figure 2E (“ChCs est” are FGF13+GABA+Reelin- bottom graph). (H) Density of 
chandelier cells in layer II/III of the mouse prefrontal cortex at P30 upon Tamoxifen 
induction at E17 or P2. Note that significantly more chandelier cells are labeled by 
embryonic induction. **p<0.01, Student t-test. (I) Fraction of FGF13+ cells in layer II/III 
that are chandelier cells at P30 upon Tamoxifen induction at E17 or P2. Note that the 
percentage of FGF13+ cells that are chandelier cells is significantly higher upon 
embryonic induction. *p<0.05, Student t-test. Based on the data from (H) and (I), 
GABAergic cells that are not positive for any known marker are likely chandelier cells 
that are not labeled by the Tamoxifen induction.  
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Fig. S11. Expression of Cbln4, Lgi2 and FGF13 in the hippocampus. 
(A) Percentage of Cbln4+ cells (detected by in situ hybridization) that express SST, PV, 
Prox1 or VIP in the mouse hippocampus (ages and labeling strategies as in figure S10). 
Note that SST+PV+ cells are included in the SST/Cbln4 bar. Percentage of SST+ cells 
that express Cbln4 in the mouse hippocampus at P30 (right). (B) Percentage of Lgi2+ 
cells (detected by in situ hybridization) that express PV, SST, Prox1 or VIP in the mouse 
hippocampus (ages and labeling strategies as in figure S10). Note that SST+PV+ cells are 
included in the PV/Lgi2 bar. Percentage of PV+ cells that express Lgi2 in the mouse 
hippocampus at P30 (right). (C) Percentage of chandelier cells (PV+/SATB1-, as 
reported by (59)) that are FGF13+ in the mouse hippocampus at P30. (D) Analysis of the 
identity of FGF13+ cells in the mouse hippocampus at P30 by colocalizing FGF13 with 
different markers. All FGF13+ cells are GABAergic and a large proportion (~30%) are 
PV+ chandelier cells (PV+/SATB1-). Few FGF13+ cells are Reelin+ (3%), 
PV+/SATB1+ (2.6%) and VIP+ (2.1%). 
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Fig. S12. In vitro and in vivo validation of the downregulation efficiency. 
(A) Map of the viral Cre-dependent constructs expressing mCherry and the miR-based 
shRNAs used for the knock-down experiments. (B) Cbln4, Lgi2 and Fgf13 mRNA 
expression assessed by qPCR (as expression relative to control) upon co-transfection of 
HEK cells with the expression plasmids for the different HA-tagged proteins and 
corresponding shRNAs (n = 3 wells). *p<0.05, **p<0.01, ***p<0.001, One-way 
ANOVA followed by Holm-Sidak’s multiple comparisons test. (C) CBLN4-HA, LGI2-
HA and FGF13-HA in vitro protein expression assessed by Western Blot upon 
downregulation using the shRNAs selected for the in vivo experiments. (D) Cbln4 
(shCbln4, n = 3 mice, control, n = 3 mice) and Lgi2 (shLgi2, n = 4 mice; control, n= 9 
mice injected with the control virus) mRNA expression levels assessed by qPCR (as 
expression relative to the control) on the infected mouse brain tissue 25 days after 
injection of the corresponding AAVs. FGF13 protein intensity (expressed as relative to 
the control; shFgf13, n = 12 cells from 5 mice; control, n = 5 cells from 3 mice) assessed 
by IHC upon in vivo downregulation. *p<0.05, ***p<0.001, Student t-test. (E) 
Representative images (maximum projection from a confocal z-stack) showing mCherry+ 
chandelier cells from sparse viral infection. FGF13 immunoreactivity in mCherry+ 
chandelier cells was observed only in control cells but not cells expressing shFgf13. Scale 
bars equal 20 μm. 
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Fig. S13. Decrease of SST+ presynaptic terminals contacting the proximal and distal 
dendrites of pyramidal neurons in absence of Cbln4. 
(A) Representative images showing the dendrites of neurobiotin-filled pyramidal neurons 
in SST-Cre mice injected at P3 with control or shCbln4-expressing virus and analyzed at 
P30-40. The insets (raw images and masks) are showing mCherry+GAD65+ presynaptic 
boutons contacting the highlighted portions of the distal dendrites. Scale bars equal 10 
μm. (B) Cumulative probability plots for mCherry contact density onto 10 μm-long 
segments of dendrite (total length analyzed: 0-100 μm from the soma) in SST-Cre mice 
injected with control (n = 57 segments from 4 cells, 3 mice) or shCbln4-expressing (n = 
33 segments from 3 cells, 3 mice). Kolmogorov-Smirnov test, p = 0.0051. (C) mCherry 
average contact density onto 10 μm-long segments of proximal (total length analyzed: 0-
40 μm from the soma) or distal (total length analyzed: 40-160 μm from the soma) 
dendrites in SST-Cre mice injected with control (n = 16 proximal and 40 distal dendritic 
segments from 4 cells, 3 mice) or shCbln4-expressing (n = 12 proximal and 21 distal 
dendritic segments from 3 cells, 3 mice). Two-way ANOVA, control vs shCbln4 p = 
0.0086, proximal vs distal p = 0.0039, interaction p = 0.9879. Sidak’s multiple 
comparisons: control vs shCbln4 in proximal dendrite p = 0.1924, control vs shCbln4 in 
distal dendrite p = 0.0449, control in proximal vs distal dendrite p = 0.0435, shCbln4 in 
proximal vs distal dendrite p = 0.1114 (D) Linear regression lines of mCherry+ contact 
density onto 10 μm-long consecutive dendritic segments (total length analyzed: 0-100 μm 
from the soma) in SST-Cre mice injected with control (n = 4 cells from 3 mice/segment) 
or shCbln4-expressing (n = 3 cells from 3 mice/segment). Linear regression analysis, p = 
0.2458, showing that the differences between the slopes are not significant. (E) 
Cumulative probability plots for mCherry+GAD65+ presynaptic bouton density onto 10 
μm-long segments of dendrite (total length analyzed: 0-100 μm from the soma) in SST-
Cre mice injected with control (n = 41 segments from 3 cells, 3 mice) or shCbln4-
expressing (n = 23 segments from 2 cells, 2 mice). Kolmogorov-Smirnov test, p = 
0.0012. (F) mCherry+GAD65+ average presynaptic bouton density onto 10 μm-long 
segments of proximal (total length analyzed: 0-40 μm from the soma) or distal (total 
length analyzed: 40-160 μm from the soma) dendrites in SST-Cre mice injected with 
control (n = 12 proximal and 29 distal dendritic segments from 3 cells, 3 mice) or 
shCbln4-expressing (n = 8 proximal and 15 distal dendritic segments from 2 cells, 2 
mice). Two-way ANOVA, control vs shCbln4 p = 0.0456, proximal vs distal p = 0.0260, 
interaction p = 0.9165. Sidak’s multiple comparisons: control vs shCbln4 in proximal 
dendrite p = 0.4266, control vs shCbln4 in distal dendrite p = 0.1264, control in proximal 
vs distal dendrite p = 0.1121, shCbln4 in proximal vs distal dendrite p = 0.3139. (G) 
Linear regression lines of mCherry+GAD65+ presynaptic bouton density onto 10 μm-
long consecutive dendritic segments (total length analyzed: 0-100 μm from the soma) in 
SST-Cre mice injected with control (n = 3 cells from 3 mice/segment) or shCbln4-
expressing (n = 2 cells from 2 mice/segment). Linear regression analysis, p = 0.1400, 
showing that the differences between the slopes are not significant. 
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Fig. S14. Disorganization of the chandelier cell arbor upon early but not late loss of 
Fgf13. 
(A and B) Representative images showing sparser arborization and disorganization of 
chandelier axons at P30 in FGF13 knock-down cells (B) compared to control cells 
infected with a control virus (A). Scale bars equal 10 μm. (C) Quantification of the 
‘distance to closest cartridge’ (measured as the average distance between each cartridge 
and the cartridge that is closest to it and used as a proxy to estimate the density of the 
chandelier arbor) in FGF13 knock-down cells (n = 17 cells from 3 mice) compared to 
controls (n = 13 cells from 3 mice). **p<0.01, Mann Whitney test. (D) Quantification of 
the number of axon initial segments contacted by one cartridge in FGF13 knock-down 
cells (n = 16 cells from 3 mice) compared to controls (n = 13 cells from 3 mice). 
***p<0.001, Mann Whitney test. Quantification of the average cartridge length in FGF13 
knock-down cells (n = 14 cells from 3 mice) compared to controls (n = 16 cells from 3 
mice). ***p<0.001, Student t-test. Quantification of the average AIS length in shFgf13 
injected mice (n = 3 mice) compared to controls (n = 4 mice). ns, Student t-test. (E) 
Quantification of the number of axon initial segments contacted by one cartridge in 
FGF13 knock-down cells (n = 9 cells from 5 PVCre/+ mice) compared to controls (n = 15 
cells from 5 PVCre/+ mice). ns, Student t-test. Quantification of the average cartridge 
length in FGF13 knock-down cells (n = 9 cells from 5 PVCre/+ mice) compared to controls 
(n = 14 cells from 5 PVCre/+ mice). ns, Student t-test. Quantification of the ‘distance to 
closest cartridge’ in FGF13 knock-down cells (n = 9 cells from 5 PVCre/+ mice) compared 
to controls (n = 20 cells from 5 PVCre/+ mice). **p<0.01, Mann Whitney test. (F and G) 
Representative images and Imaris reconstruction showing the reduced density of 
chandelier presynaptic boutons contacting the axon initial segment in PVCre/+ mice 
infected with control or shFgf13-expressing virus. Scale bar equal 3 μm. (H) 
Quantification of the average density of mCherry+ synapses per surface unit of axon 
initial segment (AnkG) made by chandelier cells in PVCre/+ mice infected with control (n 
= 14 cells from 5 mice) or shFgf13-expressing virus (n = 9 cells from 5 mice). *p<0.05, 
Student t-test.  
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Fig. S15. Normal axonal morphology in SST+ cells expressing shCbln4 and PV+ 
cells expressing shLgi2. 
(A) Schematic of AAV in utero injections in E14.5 SST-Cre mice. (B) Representative 
images showing the morphology of control and shCbln4-expressing Martinotti cells from 
layer V of the somatosensory cortex at P21. (C, D) Quantification of the total axonal 
length and cumulative frequency plots for the length of Martinotti cell axons in layer I 
(C) and layers II/III (D) (n = 25 neurons from 8 mice, shControl, n = 27 neurons from 5 
mice, shCbln4). No significant differences, Student t-test. (E) Schematic of AAV in utero 
injections in E15.5 Lhx6Cre/+ mice. Representative images showing the morphology of 
control and shLgi2-expressing PV+ basket cells from layer V of somatosensory cortex at 
P21. (F) Quantification of the total axonal length and cumulative frequency plots for the 
length of PV+ basket cell axons in layer V (n = 22 neurons from 5 mice, shControl, n = 
23 neurons from 4 mice, shLgi2). No significant differences, Student t-test. 
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Fig. S16. In vivo rescue of the downregulated genes confirms the specificity of the 
synaptic phenotype. 
(A) Schematic of AAV injections at P2-P3 in the indicated regions analyzed at P30 and 
Cre-expressing mice. (B) Quantification of GAD65+ boutons inside the mCherry+ axons 
of SST+ cells contacting Gephyrin+ postsynaptic clusters in layer I of the somatosensory 
cortex of SST-Cre mice injected at P3 with control (n = 8 mice, same data as in Fig. 3C) 
or shCbln4- (n = 8 mice, same data as in Fig. 3C) or Cbln4-HA expressing virus (n = 8 
mice). **p<0.01, Kruskal-Wallis test followed by Holm-Sidak’s multiple comparisons 
test. (C) Quantification of mCherry+Syt2+ somatic synapses per surface unit of 
pyramidal cell soma in Lhx6Cre/+ mice injected at P3 with control (n = 6 mice, same data 
as in figure 3E) or shLgi2- (n = 7 mice, same data as in figure 3E) or Lgi2-HA expressing 
virus (n = 9 mice). ***p<0.01, Kruskal-Wallis test. (D) Quantification of mCherry+ 
synapses per surface unit of axon initial segment (AnkG) made by PVCre/+ chandelier 
cells infected at P2 with control (n = 58 AIS from 8 mice), shFgf13- (n = 35 AIS from 6 
mice), Fgf13A-Flag (n = 21 AIS from 6 mice) or Fgf13B-HA expressing virus (n = 38 
AIS from 6 mice, mFgf13B). *p<0.05, **p<0.01, ***p<0.001, Kruskal-Wallis test.  
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Fig. S17. Downregulation of Cbln4, Lgi2 and Fgf13 does not affect synapse 
formation in other interneuron subtypes. 
(A) Left: quantification of mCherry+Syt2+ somatic synapses per surface unit of 
pyramidal cell soma in Lhx6Cre/+ mice injected at P3 with control (n = 3 mice) or 
shCbln4-expressing virus (n = 3 mice) and analyzed in the somatosensory cortex at P27. 
No significant differences, Student t-test. Right: quantification of mCherry+Syt2+ 
boutons inside the mCherry+ axons of sparsely labeled PV+ cells contacting Gephyrin+ 
postsynaptic clusters in the lower layers of the prefrontal cortex of Nkx2-1CreER/+ mice 
induced with Tamoxifen and infected at P2 with control (n = 9 cells from 4 mice) or 
shCbln4-expressing virus (n = 6 cells from 3 mice) and analyzed at P25. No significant 
differences, Mann-Whitney test. Note that the use of Lhx6Cre/+ mice (left bar graph) 
implies having both PV+ and SST+ cells that are knockdown for Cbln4. The use of Nkx2-
1CreER/+ mice (right bar graph) allowed sparse labeling and hence ensured a cell-
autonomous effect of the downregulation in PV+ cells only. (B) Quantification of 
mCherry+ synapses per surface unit of axon initial segment (AnkG) made by Nkx2-
1CreER/+ chandelier cells induced with Tamoxifen and infected at P2 with control (n = 8 
cells from 2 mice) or shCbln4-expressing virus (n = 14 cells from 3 mice) and analyzed at 
P25. No significant differences, Student t-test. (C) Quantification of GAD65+ boutons 
inside the mCherry+ axons of SST+ cells contacting Gephyrin+ postsynaptic clusters in 
layer I of the somatosensory cortex of Lhx6Cre/+ mice injected at P3 with control (n = 6 
mice) or shLgi2-expressing virus (n = 7 mice) and analyzed at P30. No significant 
differences, Student t-test. (D) Quantification of mCherry+ synapses per surface unit of 
axon initial segment (AnkG) made by Nkx2-1CreER/+ chandelier cells induced with 
Tamoxifen and infected at P2 with control (n = 9 cells from 3 mice) or shLgi2-expressing 
virus (n = 8 cells from 3 mice) and analyzed at P25. No significant differences, Student t-
test. (E) Quantification of GAD65+ boutons inside the mCherry+ axons of SST+ cells 
contacting Gephyrin+ postsynaptic clusters in layer I of the somatosensory cortex of 
Lhx6Cre/+ mice injected at P3 with control (n = 3 mice) or shFgf13-expressing virus (n = 3 
mice) and analyzed at P27. No significant differences, Student t-test. (F) Quantification 
of mCherry+Syt2+ somatic synapses per surface unit of pyramidal cell soma in PVCre/+ 
mice injected at P3 with control (n = 4 mice) or shFgf13-expressing virus (n = 3 mice) 
and analyzed at P30. No significant differences, Mann-Whitney test. 
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Fig. S18. The number and distribution of interneurons is not affected by the absence 
of Cbln4, Lgi2 or Fgf13. 
(A) Number and distribution of SST+ cells in the mouse somatosensory cortex of SST-
Cre mice injected at P3 with control (n = 3 mice) or shCbln4-expressing virus (n = 3 
mice) and analyzed at P30. Two-way ANOVA, control vs shCbln4: p = 0.1789, layer 
effect: p = <0.0001, interaction: p = 0.1105. No significant differences were detected by 
Sidak’s multiple comparisons test between control and shCbln4. Note that analysis was 
performed in slices where 100% of SST+ cells were infected. (B) Number and 
distribution of PV+ cells in the mouse somatosensory cortex of Lhx6Cre/+ mice injected at 
P3 with control (n = 3 mice) or shLgi2-expressing virus (n = 3 mice) and analyzed at P30. 
Two-way ANOVA, control vs shLgi2: p = 0.3699, layer effect: p = <0.0001, interaction: 
p = 0.1291. Note that analysis was performed in slices where 100% of PV+ cells were 
infected. (C) Number of mCherry+ chandelier cells (normalized by the total number of 
PV+ cells infected by each virus) in the upper layers of the mouse prefrontal cortex of 
Nkx2-1CreER/+ mice induced with Tamoxifen and infected at P2 with control (n = 3 mice) 
or shFgf13-expressing virus (n = 3 mice) and analyzed at P30. No significant differences, 
Student t-test. 
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Fig. S19. Characterization of CBLN4 and LGI2 trans-synaptic partners GluD1 and 
ADAM22. 
(A-B) Representative immunoblot illustrating that pull-down of Cbln4-HA and Lgi2-HA 
co-immunoprecipitates (IP), respectively, GluD1 (A) and ADAM22 (B) from wild type 
P30 cortical lysates (n = 5 experiments, 80% and 40% co-IP success rate for GluD1 and 
ADAM22, respectively). (C-D) Representative image (C) and profile plot (D) showing 
the localization of GluD1 at the GAD65+Gephyrin+ synapses made by SST+ cells in 
layer I of P30 mouse somatosensory cortex (n = 30 synapses from 3 mice). (E) 
Percentage of GAD65+Gephyrin+ synapses that colocalize with GluD1 at P30 in layer I 
of the mouse somatosensory cortex (n = 3 mice). (F-I) Representative images, imaris 
reconstructions (F-I) and density (I) of GluD1+ clusters as well as GAD65+GluD1+ 
synapses on the dendritic tufts (where the majority of SST+ synapses are made) versus 
distal dendrites or somata of pyramidal cells labeled at P3 with injection of a GFP-
expressing virus and analyzed at P30 (n = 5 mice). *p<0.05, Kruskal-Wallis test followed 
by Dunn’s multiple comparisons test. (J-K) Representative image (J) and profile plot (K) 
showing the localization of ADAM22 at the Syt2+Gephyrin+ synapses made by PV+ 
cells around the soma of pyramidal neurons at P30 (n = 30 synapses from 3 mice). (L) 
Percentage of Syt2+Gephyrin+ that colocalize with ADAM22 at P30 in the mouse 
somatosensory cortex (n = 3 mice). Scale bars equal 4 μm. 
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Fig. S20. Pcdh18 is specifically expressed in SST+ cells and regulates the 
development of SST+ synapses. 
(A) Developmental expression of Pcdh18 in the mouse somatosensory cortex assessed by 
qPCR as expression relative to 18S (n = 3 mice for each stage). *p<0.05 for P5 vs P10, 
P15 vs P20 and P15 vs P30; **p<0.01 for P10 vs P20 and P10 vs P30; One-Way 
ANOVA followed by Tukey’s multiple comparisons test. Note that significance is shown 
only for the P5-P10 comparison. (B) Representative image showing the colocalization of 
Pcdh18 mRNA with SST+ cells. Scale bar equal to 20 μm. (C) Quantification of the 
specificity of Pcdh18 expression in SST+ interneurons subpopulations at P10 and P30 (n 
≥ 3 mice for each stage). (D) Fraction of SST+ cells that express Pcdh18 at P10 and P30 
(n ≥ 3 mice for each stage). (E) Percentage of Pcdh18+ cells (detected by in situ 
hybridization) that express SST in the indicated layers of the mouse somatosensory 
cortex at P10 and P30 (n ≥ 3 mice for each stage). (F) Percentage of SST+ cells that 
express Pcdh18 in the indicated layers of the mouse somatosensory cortex at P10 and P30 
(n ≥ 3 mice for each stage). (G) Pcdh18 mRNA expression (relative to 18S) assessed by 
qPCR (and shown as expression relative to control) upon co-transfection of HEK cells 
with an HA-tagged Pcdh18 expression plasmid and corresponding shRNAs (n = 2 
experiments. (H) Schematic of AAV injections in the somatosensory cortex of SST-Cre 
mice. (I-J) Representative image, Imaris reconstruction (I) and quantification (J) of 
GAD65+ boutons inside the mCherry+ axons of SST+ cells contacting Gephyrin+ 
postsynaptic clusters in layer I of the somatosensory cortex of SST-Cre mice injected at 
P3 with control (n = 3 mice) or shPcdh18-expressing virus (n = 3 mice) and analyzed at 
P30. **p<0.01, Student t-test. Scale bar equal 3 μm. 
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Fig. S21. Functional reduction in SST dendritic inhibition upon loss of function of 
Cbln4. 
(A) Schematic of AAV injections in the indicated regions and Cre-expressing mice and 
optogenetic activation. (B) Example responses to current steps delivered for intrinsic 
property analysis for SST interneurons in the somatosensory cortex of SST-Cre mice 
injected at P3 with control or shCbln4-expressing virus. (C) Number of spikes elicited 
per optogenetic stimulus as a function of irradiance (control, n = 16 cells; shCbln4 n = 19 
cells), ns, Two-Way ANOVA. (D) Intrinsic properties for SST interneurons recorded 
from control or shCbln4-injected mice. (E) Spike probability as a function of irradiance 
(control, n = 16 cells; shCbln4 n = 19 cells), ns, Two-Way ANOVA. (F) Intrinsic 
properties for SST interneurons recorded from mice injected with control or shCbln4-
virus. 
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Fig. S22. Overexpression of CBLN4 in PV+ and chandelier cells alters their 
synapses in a domain-specific manner. 
(A) Quantification of mCherry-Syt2+ somatic synapses per surface unit of pyramidal cell 
soma in PVCre/+ mice injected at P3 with control (n = 5 mice) or Cbln4-HA-expressing 
virus (n = 5 mice). ns, Student t-test. (B) Relative frequency distribution of Syt2+ 
presynaptic boutons per surface unit of pyramidal cell soma in PVCre/+ mice injected at P3 
with control (n = 5 mice) or Cbln4-HA-expressing virus (n = 5 mice). ns, Kolmogorov-
Smirnov test. (C) Quantification of Syt2+ presynaptic boutons per surface unit of 
pyramidal cell soma in Lhx6Cre/+ mice injected at P3 with control (n = 5 mice) or Cbln4-
HA-expressing virus (n = 5 mice). ns, Student t-test. (D) Quantification of mCherry-
Syt2+ somatic synapses per surface unit of pyramidal cell dendrite in PVCre/+ mice 
injected at P3 with control (n = 5 mice) or Cbln4-HA-expressing virus (n = 5 mice). ns, 
Student t-test. (E) Relative frequency distribution of Syt2+ presynaptic boutons per 
surface unit of pyramidal cell dendrite in PVCre/+e mice injected at P3 with control (n = 5 
mice) or Cbln4-HA-expressing virus (n = 5 mice). **p<0.01, Kolmogorov-Smirnov test. 
(F) Quantification of Syt2+ presynaptic boutons per surface unit of pyramidal cell 
dendrite in PVCre/+ mice injected at P3 with control (n = 5 mice) or Cbln4-HA-expressing 
virus (n = 5 mice). ns, Student t-test. (G) Quantification of mCherry+VGAT+ axo-axonic 
synapses per surface unit of axon initial segment (AIS) in PVCre/+ mice injected at P3 
with control (n = 3 mice) or Cbln4-HA-expressing virus (n = 3 mice). ns, Mann Whitney 
test. Note that, excluding cartridges from chandelier cells, PV+ cells make virtually no 
axo-axonic synapse. Because Syt2 is found only at PV+ somatic synapses, VGAT was 
used here on the assumption that PV+ ectopic synapses onto the AIS may lose Syt2. (H) 
Quantification of mCherry+ synapses per surface unit of pyramidal cell soma made by 
Nkx2-1CreER/+ chandelier cells induced with Tamoxifen at P2 and infected with control (n 
= 9 cells from 3 mice) or Cbln4-HA-expressing virus (n = 8 cells from 3 mice). ns, Mann 
Whitney test. (I) Quantification of mCherry+ synapses per surface unit of pyramidal cell 
dendrite made by Nkx2-1CreER/+ chandelier cells induced with Tamoxifen at P2 and 
infected with control (n = 11 cells from 3 mice) or Cbln4-HA-expressing virus (n = 11 
cells from 3 mice). ns, Mann Whitney test. 
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Table S1. Transgenic lines, brain regions and stages used for gene expression 
profiling. 
Table S2. RNA integrity numbers for all samples
RIN
SST_P10 9.2
SST_P10 8.2
SST_P10 8.8
SST_P5 9.3
SST_P5 7.4
SST_P5 9.9
PVBC_P10 8.9
PVBC_P10 7.7
PVBC_P10 6.9
PVBC_P5 9.3
PVBC_P5 7.2
PVBC_P5 8.9
ChC_P10 9.5
ChC_P10 8.7
ChC_P10 9.7
ChC_P8 9.6
ChC_P8 7.6
ChC_P8 6.3
PYR_P12 10
PYR_P12 9.3
PYR_P12 10
IN_P0 6.5
IN_P0 7.7
IN_P0 8.9
OLIG_P10 9.9
OLIG_P10 9.6
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Table S2. RNA integrity numbers for the samples used in the RNAseq experiment. 
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Table S3. Gene expression and specificity of all transcripts from the isolated cell 
populations. Table provided as separate file. 
Table S4. Matching interneuron subtype-specific and pyramidal cell gene/protein-
pairs. Table provided as separate file. 
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